Skip to main content

Full Schedule

Full Schedule

  • Monday, November 1, 2021
  • 10:00 AM – 10:30 AM ET
    How to Network in a Virtual Setting
    Virtual Room 1

    Moderator: Hanna Kim, MD, MS – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)

  • 10:00 AM – 10:15 AM ET
    Networking ACR Convergence
    Virtual Room 1

    Panel: Grant Schulert, MD, PhD – Cincinnati Children's Hospital Medical Center

    Panel: Laura B. Lewandowski, MD – NIAMS, NIH

  • 10:15 AM – 10:30 AM ET
    Virtual Networking: Successes & Challenges
    Virtual Room 1

    Speaker: Kamala Nola, MS, PharmD – Lipscomb University College of Pharmacy

  • Wednesday, November 3, 2021
  • 7:30 AM – 8:45 AM ET
    Global Summit: Opening Session
    Virtual Room 1

    Moderator: Evelyn Hsieh, MD, PhD – Yale School of Medicine

  • 7:30 AM – 7:45 AM ET
    Welcome & Recognition of Distinguished International Rheumatology Professional Award
    Virtual Room 1

    Speaker: David Karp, MD;PhD – UT Southwestern Medical Center

  • 7:45 AM – 8:30 AM ET
    Keynote: Bridging Divides and Fostering Dialogue to Achieve Health Equity
    Virtual Room 1

    Speaker: Ayoade Alakija, MD, MSc – AOA and Associates

  • 8:30 AM – 8:45 AM ET
    Q&A
    Virtual Room 1
  • 8:45 AM – 9:00 AM ET
    Break
    Virtual Room 1
  • 9:00 AM – 10:15 AM ET
    Global Summit: Meet the Experts
    Virtual Room 1

    Moderator: Abhishek Nandan, MD – Virginia Commonwealth University

    Moderator: Catalina Sanchez Alvarez, MD – University of Florida

    Panel: Masayoshi Harigai, MD, PhD – Tokyo Women's Medical University

    Panel: Rona Smith, MD – University of Cambridge

    Panel: Luis Felipe Flores-Suarez, MD, PhD – Instituto Nacional de Enfermedades Respiratorias

  • 9:00 AM – 9:05 AM ET
    Introduction
    Virtual Room 1
  • 9:05 AM – 9:10 AM ET
    Autoinflammatory Features in ANCA-associated Vasculitis
    Virtual Room 1

    Speaker: Chiara Marvisi – Università di Modena e Reggio Emilia

  • 9:10 AM – 9:20 AM ET
    Q&A
    Virtual Room 1
  • 9:20 AM – 9:25 AM ET
    Perseverance Put to Test: Refractory ANCA-associated Vasculitis
    Virtual Room 1

    Speaker: Sandeep yadav, MD – Pd Hinduja hospital

  • 9:25 AM – 9:35 AM ET
    Q&A
    Virtual Room 1
  • 9:35 AM – 9:40 AM ET
    The Vitriol of Vaccines and Vasculitis
    Virtual Room 1

    Speaker: Gabriela Martinez Zayas, MD – UT Southwestern

  • 9:40 AM – 9:50 AM ET
    Q&A
    Virtual Room 1
  • 9:50 AM – 9:55 AM ET
    But We Gave Rituximab!
    Virtual Room 1

    Speaker: Sujata Ganguly, MD, DM – Regency Health

  • 9:55 AM – 10:05 AM ET
    Q&A
    Virtual Room 1
  • 10:05 AM – 10:15 AM ET
    Wrap-Up
    Virtual Room 1
  • 10:15 AM – 11:15 AM ET
    Global Summit: Global Leaders Fireside Chat – Women Leaders in Rheumatology
    Virtual Room 1

    Moderator: Laura B. Lewandowski, MD – NIAMS, NIH

  • 10:15 AM – 10:25 AM ET
    Perspective 1
    Virtual Room 1

    Panel: Graciela Alarcón, MD, MPH – The University of Alabama at Birmingham

  • 10:25 AM – 10:35 AM ET
    Perspective 2
    Virtual Room 1

    Panel: Najia Hajjaj-Hassouni, MD – International University of Rabat (UIR)

  • 10:35 AM – 10:45 AM ET
    Perspective 3
    Virtual Room 1

    Panel: Lyn March, PhD;MBBS;FRACP;MSc – Institute of Bone and Joint Research, Kolling Institute, University of Sydney; Department of Rheumatology, Royal North Shore Hospital, Northern Sydney Local Health District

  • 10:45 AM – 10:55 AM ET
    Perspective 4
    Virtual Room 1

    Panel: Amita Aggarwal, MD, MBBS, DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

  • 10:55 AM – 11:15 AM ET
    Q&A
    Virtual Room 1
  • 11:15 AM – 11:30 AM ET
    Break
    Virtual Room 1
  • 11:30 AM – 12:30 PM ET
    Global Summit: Innovative Solutions to Global Challenges in Rheumatology
    Virtual Room 1

    Moderator: Ali Duarte-Garcia, MD, MSc – Mayo Clinic

    Moderator: Lesley Jackson, MD – University of Alabama at Birmingham

  • 11:30 AM – 11:40 AM ET
    Virtual Education: A Step Forward in Equitable Rheumatology Education
    Virtual Room 1

    Speaker: Michele Meltzer, MD – Thomas Jefferson University/Rheumatology for All,Inc.

  • 11:40 AM – 11:45 AM ET
    Q&A
    Virtual Room 1
  • 11:45 AM – 11:55 AM ET
    WALK RUN SPRINT - a submission on behalf of the Paediatric Global MSK Task Force
    Virtual Room 1

    Speaker: Helen Foster, MD – Newcastle University

  • 11:55 AM – 12:00 PM ET
    Q&A
    Virtual Room 1
  • 12:00 PM – 12:10 PM ET
    Improving Outcomes for Patients with Lupus Nephritis Through Early Diagnosis and Self-management
    Virtual Room 1

    Speaker: Cindy Flower, MBBS, DM, FACP – Queen Elizabeth Hospital

  • 12:10 PM – 12:15 PM ET
    Q&A
    Virtual Room 1
  • 12:15 PM – 12:25 PM ET
    Chinese Rheumatism Data Center (CRDC): A Registry-based Telehealth Platform
    Virtual Room 1

    Speaker: Qian Wang

  • 12:25 PM – 12:30 PM ET
    Q&A
    Virtual Room 1
  • 12:30 PM – 12:40 PM ET
    Building Capacity for Pediatric Rheumatology Nursing in South Africa
    Virtual Room 1

    Speaker: Chris Scott, MBChB – University of Cape Town

  • 12:30 PM – 1:30 PM ET
    Global Summit: Engaging the Full Rheumatology Care Team to Improve Patient Care and Outcomes
    Virtual Room 1

    Moderator: Jonathan Hausmann, MD – Boston Children's Hospital / Beth Israel Deaconess Medical Center

    Moderator: Sara Kellahan, NP – Washington University School of Medicine

  • 12:40 PM – 12:45 PM ET
    Q&A
    Virtual Room 1
  • 12:45 PM – 12:55 PM ET
    Empowering Patients in Rheumatology Research and Care Delivery
    Virtual Room 1

    Speaker: Emily Sirotich, BSc – McMaster University

  • 12:55 PM – 1:00 PM ET
    Q&A
    Virtual Room 1
  • 1:00 PM – 1:10 PM ET
    Developing and Using Functional Outcomes Assessments in Patients with RMDs in a Team Setting
    Virtual Room 1

    Speaker: Helene Alexanderson, RPT – Karolinska Institutet

  • 1:10 PM – 1:15 PM ET
    Q&A
    Virtual Room 1
  • 1:15 PM – 1:25 PM ET
    Training Physiotherapists and Occupational Therapists in RMD Rehabilitation to Advance the Care of Patients
    Virtual Room 1

    Speaker: Anamaria Jones, PhD – Universidade Federal de Sao Paulo

  • 1:25 PM – 1:30 PM ET
    Q&A
    Virtual Room 1
  • 1:30 PM – 2:15 PM ET
    Global Summit: Global Researcher Spotlight
    Virtual Room 1

    Moderator: Jose U. Scher, MD – New York University School of Medicine

  • 1:30 PM – 2:05 PM ET
    Lessons on the Ground from the Global Burden of Diseases Study
    Virtual Room 1

    Speaker: Christopher Murray, MD – IHME

  • 2:05 PM – 2:15 PM ET
    Q&A
    Virtual Room 1
  • 2:15 PM – 2:30 PM ET
    Break
    Virtual Room 1
  • 2:30 PM – 3:30 PM ET
    Global Summit: The Future of Rheumatology Around the Globe
    Virtual Room 1

    Moderator: Evelyn Hsieh, MD, PhD – Yale School of Medicine

    Moderator: Eric L. Matteson, MD, MPH – Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

  • 2:30 PM – 2:35 PM ET
    PANLAR Perspective
    Virtual Room 1

    Panel: Sebastian Herrera Uribe, MD – Las Américas Auna

  • 2:35 PM – 2:40 PM ET
    EULAR Perspective
    Virtual Room 1

    Panel: Kim Lauper, MD – Geneva University Hospitals

  • 2:40 PM – 2:45 PM ET
    APLAR Perspective
    Virtual Room 1

    Panel: Anthony Sammel, PhD, MBBS – Prince of Wales Hospital

  • 2:45 PM – 2:50 PM ET
    AFLAR Perspective
    Virtual Room 1

    Panel: Uyiekpen Ima-Edomwomyi, MD – Lagos University Teaching Hospital

  • 2:50 PM – 2:55 PM ET
    ACR Perspective
    Virtual Room 1

    Panel: Laura Cappelli, MD – Johns Hopkins School of Medicine

  • 2:55 PM – 3:30 PM ET
    Roundtable Discussion
    Virtual Room 1
  • Thursday, November 4, 2021
  • 9:00 AM – 5:50 PM ET
    Basic and Clinical Research Conference Day 1 of 2: Rheumatology Complications of Emerging Viral Infections / SARS-CoV-2
    Virtual Room 1

    Moderator: Randy Q. Cron, MD, PhD – University of Alabama at Birmingham

    Moderator: Mary Crow, MD – Hospital for Special Surgery

    Moderator: Alexei Grom, MD – Cincinnati Children's Hospital Medical Center

    Moderator: Frances Lund, PhD – University of Alabama at Birmingham

  • 9:00 AM – 9:20 AM ET
    Overview: Opening Remarks
    Virtual Room 1

    Speaker: Philip Krause, MD – Food and Drug Administration

  • 9:20 AM – 9:45 AM ET
    Overview: COVID-19 Vaccines for Immunocompromised Hosts
    Virtual Room 1

    Speaker: Peter J. Hotez, MD, PhD – Baylor College of Medicine

  • 9:45 AM – 10:00 AM ET
    Q&A
    Virtual Room 1
  • 10:00 AM – 10:25 AM ET
    Overview: Impact of COVID-19 in Patients with Rheumatologic Conditions
    Virtual Room 1

    Speaker: Jinoos Yazdany, MD, MPH – UCSF

  • 10:25 AM – 10:40 AM ET
    Q&A
    Virtual Room 1
  • 10:40 AM – 10:50 AM ET
    Break
    Virtual Room 1
  • 10:50 AM – 11:15 AM ET
    COVID-19-Induced Autoimmunity: Autoantibodies to Type I Interferon & Other Cytokines
    Virtual Room 1

    Speaker: Steven Holland, MD – NIH, NIAID

  • 11:15 AM – 11:30 AM ET
    Q&A
    Virtual Room 1
  • 11:30 AM – 11:55 AM ET
    COVID-19 Induced Autoimmunity: Auto-Immunity Responses
    Virtual Room 1

    Speaker: Iñaki Sanz, MD – Emory University School of Medicine

  • 11:55 AM – 12:10 PM ET
    Q&A
    Virtual Room 1
  • 12:10 PM – 1:00 PM ET
    Lunch
    Virtual Room 1
  • 1:00 PM – 1:25 PM ET
    COVID-19 Hyper-inflammation: MIS-C & Other Pediatric Complications
    Virtual Room 1

    Speaker: Mary Beth Son, MD – Boston Children's Hospital

  • 1:25 PM – 1:40 PM ET
    Q&A
    Virtual Room 1
  • 1:40 PM – 2:05 PM ET
    COVID-19 Hyper-inflammation: Cytokine Storm Syndrome
    Virtual Room 1

    Speaker: Puja Mehta, MD – University College London (UCL)

  • 2:05 PM – 2:20 PM ET
    Q&A
    Virtual Room 1
  • 2:20 PM – 2:45 PM ET
    COVID-19 Hyper-inflammation: Rheumatologic DMARD/Biologic Use
    Virtual Room 1

    Speaker: Randy Q. Cron, MD, PhD – University of Alabama at Birmingham

  • 2:45 PM – 3:00 PM ET
    Q&A
    Virtual Room 1
  • 3:00 PM – 3:10 PM ET
    Break
    Virtual Room 1
  • 3:10 PM – 3:35 PM ET
    The Immunology of COVID-19: Neutrophil Dysregulation & NETs
    Virtual Room 1

    Speaker: Mariana Kaplan, MD – NIH

  • 3:35 PM – 3:50 PM ET
    Q&A
    Virtual Room 1
  • 3:50 PM – 4:15 PM ET
    Immunology of COVID-19: Kallikrein-Kinin Blockade
    Virtual Room 1

    Speaker: Frank van de Veerdonk – Radboud University

  • 4:15 PM – 4:30 PM ET
    Q&A
    Virtual Room 1
  • 4:30 PM – 4:55 PM ET
    Immunology of COVID-19: Immune Profiling in COVID-19
    Virtual Room 1

    Speaker: Orit Rozenblatt-Rosen, PhD – Broad Institute

  • 4:55 PM – 5:10 PM ET
    Q&A
    Virtual Room 1
  • 5:10 PM – 5:35 PM ET
    Immunology of COVID-19: Genetic Risk Factors
    Virtual Room 1

    Speaker: Helen Su, MD, PhD – NIH/NIAID

  • 5:35 PM – 5:50 PM ET
    Q&A
    Virtual Room 1
  • Friday, November 5, 2021
  • 9:00 AM – 12:00 PM ET
    Radiology Boot Camp 2021
    Virtual Room 2

    Moderator: Aimee Chen-Wiener, MSN, ARNP C – Arthritis, Autoimmune &Allergy

  • 9:00 AM – 9:45 AM ET
    MSK Imaging: Disease/Case-Based Assessment of Inflammatory Arthropathies
    Virtual Room 2

    Speaker: Kathleen Brindle, MD – The George Washington University Medical Faculty Associates

  • 9:45 AM – 10:00 AM ET
    Q&A
    Virtual Room 2

    Q&A Moderator: Aimee Chen-Wiener, MSN, ARNP C – Arthritis, Autoimmune &Allergy

    Q&A Presenter: Kathleen Brindle, MD – The George Washington University Medical Faculty Associates

  • 10:00 AM – 10:45 AM ET
    MSK Imaging: Disease/Case-Based Assessment of Productive Arthropathies
    Virtual Room 2

    Speaker: Shawn Haji-Momenian, MD – George Washington University Medical Faculty Associates

  • 10:45 AM – 11:00 AM ET
    Q&A
    Virtual Room 2
  • 11:00 AM – 11:45 AM ET
    Chest Imaging in Rheumatic Diseases
    Virtual Room 2

    Speaker: John Lichtenberger, MD – The George Washington University Medical Faculty Associates

  • 11:45 AM – 12:00 PM ET
    Q&A
    Virtual Room 2
  • 9:00 AM – 12:00 PM ET
    Basic and Clinical Research Conference Day 2 of 2: Rheumatology Complications of Emerging Viral Infections / SARS-CoV-2
    Virtual Room 2

    Moderator: Mariana Kaplan, MD – NIH

  • 9:00 AM – 9:10 AM ET
    COVID-19 Oddities: Welcome Remarks
    Virtual Room 2

    Speaker: Mariana Kaplan, MD – NIH

  • 9:10 AM – 9:35 AM ET
    COVID-19 Oddities: Implications of Distinctive Pulmonary Immunovascular Thrombosis in COVID-19 Pneumonia
    Virtual Room 2

    Speaker: Dennis McGonagle, PhD, MB, FRCPI – University of Leeds

  • 9:35 AM – 9:50 AM ET
    Q&A
    Virtual Room 2
  • 9:50 AM – 10:15 AM ET
    COVID-19 Oddities: Long Haulers
    Virtual Room 2

    Speaker: Elisa Gremese, MD – Catholic University of the Sacred Heart

  • 10:15 AM – 10:30 AM ET
    Q&A
    Virtual Room 2
  • 10:30 AM – 10:40 AM ET
    Break
    Virtual Room 2
  • 10:40 AM – 11:00 AM ET
    COVID-19 Late Breaking Abstracts: Late Breaking Session
    Virtual Room 2
  • 11:00 AM – 11:15 AM ET
    Q&A
    Virtual Room 2
  • 11:15 AM – 11:40 AM ET
    COVID-19 Late Breaking Abstracts: Late Breaking Session
    Virtual Room 2
  • 11:40 AM – 11:55 AM ET
    Q&A
    Virtual Room 2
  • 11:55 AM – 12:00 PM ET
    COVID-19 Late Breaking Abstracts: Closing Remarks
    Virtual Room 2

    Speaker: Mariana Kaplan, MD – NIH

  • 2:00 PM – 3:30 PM ET
    Opening Session
    Virtual Room 1

    Moderator: David Karp, MD, PhD – UT Southwestern Medical Center

  • 2:00 PM – 2:30 PM ET
    Welcome and Presidential Address
    Virtual Room 1
  • 2:30 PM – 2:40 PM ET
    Award Recognition
    Virtual Room 1
  • 2:40 PM – 3:20 PM ET
    Keynote Lecture: The Covidization of Rheumatology: What Will or Won’t Change Beyond the Covid-19 Pandemic
    Virtual Room 1

    Executive Speaker: Seema Yasmin

  • 3:20 PM – 3:30 PM ET
    Q&A
    Virtual Room 1
  • 3:30 PM – 4:50 PM ET
    Year In Review
    Virtual Room 2

    Moderator: Sharon Kolasinski, MD – University of Pennsylvania

  • 3:30 PM – 4:00 PM ET
    Year in Review: Basic Science Rheumatology
    Virtual Room 2

    Speaker: Michael Brenner, MD – Brigham and Women's Hospital, Harvard Medical School

  • 4:00 PM – 4:10 PM ET
    Q&A
    Virtual Room 2
  • 4:10 PM – 4:40 PM ET
    Year in Review: Clinical Rheumatology
    Virtual Room 2

    Speaker: Karen Costenbader, MD, MPH – Brigham and Women's Hospital

  • 4:40 PM – 4:50 PM ET
    Q&A
    Virtual Room 2
  • Saturday, November 6, 2021
  • 7:30 AM – 8:30 AM ET
    SG01: Study Group: Childhood Sjogren's Disease Workgroup
  • 7:30 AM – 8:30 AM ET
    SG02: Study Group: CT Imaging in Rheumatology

    Coordinator: Stephanie Finzel, MD – University Clinic of Freiburg, Department of Rheumatology and Clinical Immunology

    Coordinator: Sarah Manske, Assistant Professor – University of Calgary, Department of Radiology

  • 7:30 AM – 8:30 AM ET
    SG03: Study Group: Establishing a New Normal: Developing Virtual Self-Management MSK Health Education Programs for Patients and Community

    Coordinator: Titilayo Ologhobo, MPH – Hospital for Special Surgery (HSS)

  • 7:30 AM – 8:30 AM ET
    SG04: Study Group: Immunogenomics: Towards Precision Medicine for Autoimmune Diseases

    Coordinator: Yun Liang, PhD – University of Wisconsin-Madison

  • 7:30 AM – 8:30 AM ET
    SG05: Study Group: Mark Asquith Study Group on IBD-associated SpA

    Coordinator: Kristi Kuhn, MD, PhD – University of Colorado Anschutz Medical Campus

  • 7:30 AM – 8:30 AM ET
    SG06: Study Group: Rheumatoid Arthritis Prevention

    Coordinator: Kevin D D. Deane, MD, PhD – University of Colorado Denver Anschutz Medical Campus

  • 7:30 AM – 8:30 AM ET
    SG07: Study Group: Rheumatology Reproductive Health: Can we use rheumatology medications with limited safety data during pregnancy?

    Coordinator: Megan Clowse, MD, MPH – Duke University

    Coordinator: Lisa Sammaritano, MD – Hospital for Special Surgery

  • 7:30 AM – 8:30 AM ET
    SG08: Study Group: Veterans' Affairs

    Coordinator: Elizabeth Chang, MD, MSc – PVAHCS

    Coordinator: Amy Joseph, MD – Washington University / St. Louis VA

  • 7:30 AM – 8:30 AM ET
    Challenges & Innovation in Global Rheumatology Research
    Virtual Room 5

    Moderator: Evelyn Hsieh, MD, PhD – Yale School of Medicine

  • 7:30 AM – 7:45 AM ET
    Expansion of the Rheumatology Initiative (TRI) in Ghana
    Virtual Room 5

    Speaker: Ida Dzifa Dey, MD, MSc – University of Ghana Medical School

  • 7:45 AM – 7:50 AM ET
    Q&A
    Virtual Room 5
  • 7:50 AM – 8:05 AM ET
    Overcoming Obstacles to Research Dissemination & Publication from Latin America
    Virtual Room 5

    Speaker: Manuel Francisco Ugarte Gil, MD, MSc – Hospital Guillermo Almenara Irigoyen. EsSalud

  • 8:05 AM – 8:10 AM ET
    Q&A
    Virtual Room 5
  • 8:10 AM – 8:25 AM ET
    Challenges in Conducting & Applying Epidemiologic Research in Resource-Limited Settings
    Virtual Room 5

    Speaker: Arvind Chopra, MD, MBBS, FRCP – Center for Rheumatic Diseases

  • 8:25 AM – 8:30 AM ET
    Q&A
    Virtual Room 5
  • 8:30 AM – 10:30 AM ET
    Antiphospholipid Syndrome Poster (0069–0083)
  • 8:30 AM – 10:30 AM ET
    0069: First and Recurrent Thrombosis Risk After 3842 Patient-Years of Follow-Up: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (

    Abstract Poster Presenter: yasaman ahmadzadeh, MD – Roger Williams Medical Center

  • 8:30 AM – 10:30 AM ET
    0078: Frequency and Clinical Characteristics of Secondary Antiphospholipid Syndrome in Systemic Lupus Erythematosus: The Georgia Lupus Registry

    Abstract Poster Presenter: Jinan Al-naqeeb, MD – Emory University

  • 8:30 AM – 10:30 AM ET
    0079: Association Between Preconception Complement Levels and Use of Hydroxychloroquine with Pregnancy Outcome in Patients with Primary Antiphospholipid Syndrome and Carriers of Antiphospholipid Antibodies: An International Multicenter Study

    Abstract Poster Presenter: Daniele Lini – Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia

  • 8:30 AM – 10:30 AM ET
    0080: One Point Increase in the Initial Damage as Measured by the Damage Index for Antiphospholipid Syndrome Predicts Mortality in a Multi-Ethnic Group of Thrombotic Antiphospholipid Syndrome Patients

    Abstract Poster Presenter: Pedro Gaspar, MD – Department of Internal Medicine 2, University Hospital of Santa Maria, Lisbon, Portugal

  • 8:30 AM – 10:30 AM ET
    0081: Thrombin Generation Assay and Lupus Anticoagulant Identify Different Populations of Patients with Antiphospholipid Antibodies

    Abstract Poster Presenter: Alice Barinotti, MSc – University of Turin

  • 8:30 AM – 10:30 AM ET
    0082: Association of Current Cigarette Smoking and Obesity with Antiphospholipid Antibodies and Thrombosis in 1216 International Patients Evaluated for Suspected Antiphospholipid Syndrome (APS)

    Abstract Poster Presenter: Medha Barbhaiya, MD;MPH – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0083: Cardiac Valve Surgery Outcomes in the Antiphospholipid Syndrome

    Abstract Poster Presenter: Tali Eviatar, MD – Tel Aviv Sourasky Medical Center, Israel

  • 8:30 AM – 10:30 AM ET
    0070: Pregnancy Outcomes of Antiphospholipid Antibody Positive Patients: Prospective Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Abstract Poster Presenter: Zeynep Belce Erton, MD – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0071: Damage Accrual Measured by DIAPS in Antiphospholipid Antibody (aPL)-positive Patients: Results from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Abstract Poster Presenter: Gustavo Balbi, MD – Universidade de Sao Paulo

  • 8:30 AM – 10:30 AM ET
    0072: Immunosuppression Use in Primary Antiphospholipid Antibody Positive Patients: Descriptive Analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

    Abstract Poster Presenter: Zeynep Belce Erton, MD – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0073: Anti-Domain 1 Antibody Fluctuation over Time in Patients with Persistently Positive Antiphospholipid Antibodies: Results from the Aps Action Clinical Database and Repository (“Registry”)

    Abstract Poster Presenter: Cecilia Chighizola, MD – University of Milan

  • 8:30 AM – 10:30 AM ET
    0074: Association of Anti-phospholipid Antibodies (aPL) with Poor Clinical Outcomes in Hospitalized Patients with COVID-19

    Abstract Poster Presenter: David Yaich, DO – NYU winthrop

  • 8:30 AM – 10:30 AM ET
    0075: Endothelial Cell-activating Antibodies in COVID-19

    Abstract Poster Presenter: Hui Shi, MD, PhD – University of Michigan

  • 8:30 AM – 10:30 AM ET
    0076: Predicting the Transitions Between Lupus Anticoagulant Status and Thrombosis in SLE Using a Multi-state Markov Model

    Abstract Poster Presenter: Michelle A. Petri, MD, MPH – Johns Hopkins University School of Medicine

  • 8:30 AM – 10:30 AM ET
    0077: Association of Lupus Nephritis and Other Clinical Features with Antiphospholipid Antibody Positivity Among Patients with Systemic Lupus Erythematosus

    Abstract Poster Presenter: Prarthana Jain, DO, MPH – Medical University of South Carolina

  • 8:30 AM – 10:30 AM ET
    B Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster (0001–0010)
  • 8:30 AM – 10:30 AM ET
    0001: Autoantigenic Properties Indicated for the Entire Aminoacyl tRNA Synthetase Family in Idiopathic Inflammatory Myopathies

    Abstract Poster Presenter: Charlotta Preger, MSc – Karolinska Institute

  • 8:30 AM – 10:30 AM ET
    0002: Salivary Sodium Levels in the Parotid Salivary Gland of SS Patients Suggest B-cell Mediated Epithelial Sodium Channel Disruption

    Abstract Poster Presenter: Sarah Pringle, PhD – University Medical Center Groningen

  • 8:30 AM – 10:30 AM ET
    0003: Clinically Identifiable Autoreactivity Is Common in Severe SARS-CoV-2 Infection

    Abstract Poster Presenter: Richard P. Ramonell, MD – University of Pittsburgh

  • 8:30 AM – 10:30 AM ET
    0004: Unappreciated Systemic Metabolic Functions of the Canonical B Cell Cytokines, BAFF and APRIL: Regulation of Lipolysis and Non-shivering Thermogenesis and Protection from Obesogenic Diet Induced Weight Gain

    Abstract Poster Presenter: Isaac Harley, MD, PhD, MS – University of Colorado Anschutz Medical Campus

  • 8:30 AM – 10:30 AM ET
    0005: Maturation and Dysfunction of Autoreactive B Cell Clones in Tissues of Patients with Sjögren’s Syndrome

    Abstract Poster Presenter: Rogier Thurlings, MD, PhD – Radboudumc

  • 8:30 AM – 10:30 AM ET
    0006: Metabolic Characteristics of Age-related B Cells in Lupus-prone Mice and Effects on Follicular Helper T Cells

    Abstract Poster Presenter: Ivan E E. Ramirez De Oleo, MD – Northwell

  • 8:30 AM – 10:30 AM ET
    0007: Divergent Reactivities of Rheumatoid Factors and Anti-Modified Protein Antibodies Converge on IgG Epitopes

    Abstract Poster Presenter: Miriam Shelef, MD, PhD – University of Wisconsin - Madison

  • 8:30 AM – 10:30 AM ET
    0008: Jo-1-Binding and Clonally-Expanded Memory B Cells Express Germline and Somatically-Mutated B Cell Receptors in Anti-tRNA Synthetase Syndrome Patients

    Abstract Poster Presenter: Jennifer J. Young-Glazer, MD, MS – Vanderbilt University Medical Center

  • 8:30 AM – 10:30 AM ET
    0009: Humoral Immune Responses to SARS-CoV2 Infections and upon Vaccination Against SARS-CoV2

    Abstract Poster Presenter: Stephanie Finzel, MD – University Clinic of Freiburg, Department of Rheumatology and Clinical Immunology

  • 8:30 AM – 10:30 AM ET
    0010: Relaxed Peripheral Tolerance Drives Broad de Novo Autoreactivity in Severe COVID-19

    Abstract Poster Presenter: Matthew C. Woodruff, PhD – Emory University

  • 8:30 AM – 10:30 AM ET
    Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)
  • 8:30 AM – 10:30 AM ET
    0084: COVID-19 Pneumonia in Two Hospitals: Similar Outcomes Despite Differential Use of Tocilizumab

    Abstract Poster Presenter: Leanna Wise, MD, MPH – LAC+USC/Keck Medicine of USC

  • 8:30 AM – 10:30 AM ET
    0085: Association of CD20 Inhibitor Use with Severe COVID-19 Outcomes

    Abstract Poster Presenter: Naomi J. Patel, MD – Massachusetts General Hospital

  • 8:30 AM – 10:30 AM ET
    0086: SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review

    Abstract Poster Presenter: Richard Conway, PhD, MBBCH – St. James's Hospital

  • 8:30 AM – 10:30 AM ET
    0087: TNF Inhibitors and the Risk of Adverse COVID-19 Outcomes in Patients with Immune-Mediated Inflammatory Disease: Pooled Data from Three Global Registries

    Abstract Poster Presenter: Zara Izadi, PharmD – University of California San Francisco

  • 8:30 AM – 10:30 AM ET
    0088: Evaluation of Patient Characteristics and Clinical Outcomes Among SARS‑CoV‑2‑Diagnosed Patients with and Without RA or PsA Treated with Systemic Therapies: A Retrospective Cohort Study Using US Optum® COVID-19 Electronic Health Record Data

    Abstract Poster Presenter: Jeffrey R Curtis, MD, MS, MPH – University of Alabama at Birmingham

  • 8:30 AM – 10:30 AM ET
    0089: SARS-CoV-2 Seroprevalence and Seroconversion in a Systemic Lupus Erythematosus Cohort and Comparison to General Population Controls

    Abstract Poster Presenter: Hannah Mathew, BSc – University of Calgary

  • 8:30 AM – 10:30 AM ET
    0090: Subcutaneous Sarilumab in Hospitalized Patients with Moderate-severe COVID-19 Infection Compared to the Standard Care: An Open-label Randomized Clinical Trial

    Abstract Poster Presenter: Sebastian C Rodriguez-Garcia, MD, MSc – Hospital Universitario de La Princesa

  • 8:30 AM – 10:30 AM ET
    0091: Vaccination of Patients with Chronic Inflammatory Rheumatic Diseases: An Analysis of Barriers and Facilitators in a Prospective Cohort

    Abstract Poster Presenter: Uta Kiltz, PhD – Rheumazentrum Ruhrgebiet

  • 8:30 AM – 10:30 AM ET
    0092: Clinical Outcomes of Patients with Systemic Rheumatic Diseases Hospitalized for COVID-19 at a Large Academic Center in New York City

    Abstract Poster Presenter: Caroline H. Siegel, MD – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0094: Characteristics Associated with Severe Outcomes in Patients with Systemic Rheumatic Diseases Hospitalized for COVID-19 in New York City

    Abstract Poster Presenter: Caroline H. Siegel, MD – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0095: Risk Factors for “Long Haul” COVID-19 in Rheumatology Outpatients in New York City

    Abstract Poster Presenter: Medha Barbhaiya, MD;MPH – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0096: The True Prevalence of SARS-CoV-2 Infection in an Italian Cohort of Patients with Inflammatory Arthritis: A Seroepidemiological Study

    Abstract Poster Presenter: Ennio Giulio Favalli, MD – ASST Gaetano Pini-CTO Institute, Division of Clinical Rheumatology, Milan, Italy

  • 8:30 AM – 10:30 AM ET
    0097: Outcome of SARS-CoV-2 Infection in Patients with Rheumatoid Arthritis Under Treatment with Janus Kinase Inhibitors Compared to Tumour Necrosis Factor Inhibitors

    Abstract Poster Presenter: Rebecca Hasseli, MD – Justus-Liebig-University Giessen

  • 8:30 AM – 10:30 AM ET
    0098: Patients with Chronic Inflammatory Rheumatic Diseases Report a Lower Frequency of Infections Than Controls and They Protect Themselves Well Against SARS-CoV-2 Transmission

    Abstract Poster Presenter: Alexandru Andreica, MD – Rheumazentrum Ruhrgebiet, Ruhr-University-Bochum

  • 8:30 AM – 10:30 AM ET
    0099: First Results of the BELCOMID Study: BELgian Cohort Study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID)

    Abstract Poster Presenter: Kurt de Vlam, MD;PhD – University Hospitals Leuven

  • 8:30 AM – 10:30 AM ET
    0100: Safety of COVID-19 Vaccines After First Vaccination in Patients with Rheumatic Diseases in a Patient Reported Survey

    Abstract Poster Presenter: Rebecca Hasseli, MD – Justus-Liebig-University Giessen

  • 8:30 AM – 10:30 AM ET
    0101: Herpes Zoster Recombinant Zoster Vaccination Among Adults Age ≥50 Years with Immune Mediated Inflammatory Diseases in the United States

    Abstract Poster Presenter: Jeffrey R Curtis, MD, MS, MPH – University of Alabama at Birmingham

  • 8:30 AM – 10:30 AM ET
    0102: Differential Impact of TNFi, JAKi and Rituximab on the Outcome of SARS-CoV-2 Infection in RMD Patients

    Abstract Poster Presenter: Anne Regierer, MD, PhD – German Rheumatism Research Center

  • 8:30 AM – 10:30 AM ET
    0103: Patients with Inflammatory Rheumatic Diseases Are at Increased Risk of COVID-19 Related Hospitalization: Data from a Prospective Controlled Cohort Study

    Abstract Poster Presenter: Laura Boekel, BSc – Vrije Universiteit Amsterdam

  • 8:30 AM – 10:30 AM ET
    0104: Adverse Events of First SARS-CoV-2 Vaccinations Are Comparable for Patients with Autoimmune Diseases and the General Population

    Abstract Poster Presenter: Laura Boekel, BSc – Vrije Universiteit Amsterdam

  • 8:30 AM – 10:30 AM ET
    0105: Most Patients with Spondylitis Accept COVID-19 Vaccination and Few Experience Disease Exacerbation After Immunization

    Abstract Poster Presenter: Rachel Higgins, BS, MPH – Oregon Health & Science University

  • 8:30 AM – 10:30 AM ET
    0106: COVID-19 Mortality and Hospitalization Risk in Patients with Rheumatic Diseases: A Single Center Retrospective Cohort Study

    Abstract Poster Presenter: Mousa Albalwi, MD – Utah University Hospital

  • 8:30 AM – 10:30 AM ET
    0107: Acceptability of the COVID-19 Vaccine in Patients with Rheumatic Diseases and Healthcare Professionals in 19 Arab Countries

    Abstract Poster Presenter: Lina El Kibbi, MD, FACR – Specialized Medical Center

  • 8:30 AM – 10:30 AM ET
    0108: Efficacy of SARS-CoV-2 Vaccine in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis

    Abstract Poster Presenter: Akhil Sood, MD – University of Texas Medical Branch

  • 8:30 AM – 10:30 AM ET
    0109: COVID-19 Infection and Outcomes in Patients with Rheumatic Diseases: A Systematic Review and Meta-Analysis

    Abstract Poster Presenter: Akhil Sood, MD – University of Texas Medical Branch

  • 8:30 AM – 10:30 AM ET
    0110: Mortality in 2020 Due to COVID-19 in U.S. Adults with Rheumatic Diseases: Data from a Large, National, Multi-Rheumatic Disease Registry

    Abstract Poster Presenter: Kaleb Michaud, PhD – University of Nebraska Medical Center

  • 8:30 AM – 10:30 AM ET
    0111: Risk of Hospitalization, Admission to Intensive Care and Mortality Due to COVID-19 in Patients with Rheumatic Diseases: A Population-based Matched Cohort Study

    Abstract Poster Presenter: Ana Michelle Avina-Galindo, BSc – Arthritis Research Canada

  • 8:30 AM – 10:30 AM ET
    0112: A Randomized Trial Showing No Differences in Patient Satisfaction with Telemedicine Delivered by Phone or Video During COVID-19 in Rheumatology and Other Medical Specialty Clinics

    Abstract Poster Presenter: Maria I. Danila, MD, MSc, MPH – University of Alabama at Birmingham (UAB)

  • 8:30 AM – 10:30 AM ET
    0113: Reactogenicity of the SARS-CoV-2 Vaccines Associates with Immunogenicity in Patients with Autoimmune and Inflammatory Disease

    Abstract Poster Presenter: Monica Yang, MD – UCSF

  • 8:30 AM – 10:30 AM ET
    0114: The Safety Profile of SARS-CoV-2 Vaccines Among Patients with Immune-Mediated Rheumatic Diseases

    Abstract Poster Presenter: Jose A Gomez-Puerta, MD, PhD, MPH – Hospital Clinic de Barcelona

  • 8:30 AM – 10:30 AM ET
    0115: Rheumatic Disease Management by Resilient Rheumatology Providers in COVID-19 Pandemic: A National Veterans Affairs Follow-up Survey Assessing Provider Practice and Views Since June 2020

    Abstract Poster Presenter: Jasvinder Singh Singh – University of Alabama at Birmingham

  • 8:30 AM – 10:30 AM ET
    0116: COVID-19 mRNA Vaccine Side Effects Among Individuals with Rheumatic Disease

    Abstract Poster Presenter: Kaleb Michaud, PhD – University of Nebraska Medical Center

  • 8:30 AM – 10:30 AM ET
    0117: Flares Following Herpes Zoster Recombinant Zoster Vaccination Among Adults Age ≥50 Years with Immune Mediated Inflammatory Diseases in the United States

    Abstract Poster Presenter: Jeffrey R Curtis, MD, MS, MPH – University of Alabama at Birmingham

  • 8:30 AM – 10:30 AM ET
    0093: The Association of General and Covid-19-Specific Stress with Changes in Patient-Reported Outcomes and Comorbidities

    Abstract Poster Presenter: Patricia Katz, PhD – UCSF

  • 8:30 AM – 10:30 AM ET
    Fibromyalgia & Other Clinical Pain Syndromes Poster (0118–0127)
  • 8:30 AM – 10:30 AM ET
    0127: Interleukin 1 Receptor Antagonist (IL-1Ra) Variable Number of Tandem Repeat (VNTR) Polymorphism in Fibromyalgia Patients in South India

    Abstract Poster Presenter: Arun Tiwari, MD, MBBS, DM – Amrita Institute of Medical Sciences, Kochi,Kerala, India

  • 8:30 AM – 10:30 AM ET
    0118: Multidimensional Phenotypes of Sleep Quality Using the Pittsburg Quality Sleep Index and Associations Among Sleep Dimensions and Symptoms in Women Diagnosed with Fibromyalgia

    Abstract Poster Presenter: Victoria Menzies, PhD, APRN – University of Florida

  • 8:30 AM – 10:30 AM ET
    0119: Worsened Depression but Improved Fatigue Were the Main Impacts of Severe Lockdown in Non- COVID Infected Australian Fibromyalgia Patients

    Abstract Poster Presenter: Benjamin Worcester, MBBS, BSc – Monash Health

  • 8:30 AM – 10:30 AM ET
    0120: Fibromyalgianess and Glucocorticoid Persistence Among Patients with Rheumatoid Arthritis

    Abstract Poster Presenter: Beth I. Wallace, MD, MS – Michigan Medicine, VA Ann Arbor Healthcare System

  • 8:30 AM – 10:30 AM ET
    0121: The Efficacy of Group Behavioral Activation versus Usual Treatment in Patients with Fibromyalgia and Major Depression

    Abstract Poster Presenter: Josefina Duran, n/a – Pontificia Universidad Católica de Chile

  • 8:30 AM – 10:30 AM ET
    0122: Clinical Impact of a Digital Behavioral Therapy for Fibromyalgia Management: A Randomized Controlled Trial

    Abstract Poster Presenter: Stephanie Catella – Swing Therapeutics

  • 8:30 AM – 10:30 AM ET
    0123: Vestibulocortical Stimulation with Caloric Irrigation Reduces Pain and Improves Subjective Well-Being in Fibromyalgia: An Open-Label Pilot Trial

    Abstract Poster Presenter: Michael Kaplan, MD – Mount Sinai Hospital

  • 8:30 AM – 10:30 AM ET
    0124: Nurse-supported Web-based Cognitive Behavioral Therapy for Chronic Musculoskeletal Pain: An Effectiveness Trial

    Abstract Poster Presenter: Rami Diab, MD – Wake Forest Baptist Health/Wake Forest School of Medicine

  • 8:30 AM – 10:30 AM ET
    0125: Body Mass Composition in Post-menopausal Women with Fibromyalgia: Preliminary Results from a Cross-sectional Monocentric Study

    Abstract Poster Presenter: Sabrina Paolino, MD – Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Polyclinic San Martino Hospital

  • 8:30 AM – 10:30 AM ET
    0126: Prevalence of Dyslipidemia in Fibromyalgia: A Single Center Case Control Study from South India

    Abstract Poster Presenter: Sumanth Madan, MD;MBBS;DM – Amrita Institute of Medical Sciences

  • 8:30 AM – 10:30 AM ET
    Health Services Research Poster I: Lupus, Inflammatory Arthritis, & More (0128–0148)
  • 8:30 AM – 10:30 AM ET
    0128: Increased Risk of Major Adverse Cardiac Events in Patients with Systemic Lupus Erythematosus After Non-Cardiac Surgery

    Abstract Poster Presenter: Sebastian Bruera, MD, BS – Baylor College of Medicine

  • 8:30 AM – 10:30 AM ET
    0137: Antiviral Use and Healthcare Resource Utilization Among Patients with Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016–2019

    Abstract Poster Presenter: Edward Neuberger, PharmD – Genentech, Inc.

  • 8:30 AM – 10:30 AM ET
    0138: Treatment with Adalimumab in Patients with Chronic Inflammatory Rheumatic Diseases: A Study of Treatment Trajectories on a Patient Level in Clinical Practice

    Abstract Poster Presenter: Uta Kiltz, PhD – Rheumazentrum Ruhrgebiet

  • 8:30 AM – 10:30 AM ET
    0139: Treatment of Ankylosing Spondylitis by Primary Care Physicians and Rheumatologists in an Academic Health System: A Retrospective Study

    Abstract Poster Presenter: Alexis Ogdie, MD – University of Pennsylvania

  • 8:30 AM – 10:30 AM ET
    0140: Therapeutic Management and Clinical Remission in a Specialized Dermatological-Rheumatological Center for Patients with Psoriasis and Psoriatic Arthritis

    Abstract Poster Presenter: Valentin Schäfer, MD, PhD – University Hospital Bonn

  • 8:30 AM – 10:30 AM ET
    0141: Who Gets Influenza Vaccinations Prior to and After a Diagnosis of RA? Results from the Canadian Early Arthritis Cohort (CATCH)

    Abstract Poster Presenter: Viviane Ta, MSc – McGill University

  • 8:30 AM – 10:30 AM ET
    0142: Description of a Scleroderma Cohort and Management of Lung Disease Risk at a Rural Academic Medical Center

    Abstract Poster Presenter: Jenna Marinock, MD – Geisinger Commonwealth School of Medicine

  • 8:30 AM – 10:30 AM ET
    0143: Economic and Healthcare Resource Use Burden of Systemic Sclerosis

    Abstract Poster Presenter: Dinesh Khanna, MD, MSc – University of Michigan

  • 8:30 AM – 10:30 AM ET
    0144: Healthcare Utilization and Costs Following Kawasaki Disease in Ontario, Canada

    Abstract Poster Presenter: Michelle Batthish, MD, MSc – McMaster University

  • 8:30 AM – 10:30 AM ET
    0145: Rheumatology Provider Perspectives on Using Patient-Reported Outcomes in Clinical Care

    Abstract Poster Presenter: Yomei Shaw, PhD – FORWARD, The National Databank for Rheumatic Diseases

  • 8:30 AM – 10:30 AM ET
    0146: Improving Medication Toxicity Lab Monitoring During the COVID-19 Pandemic

    Abstract Poster Presenter: Akrithi Garren, MD – MedStar/Georgetown

  • 8:30 AM – 10:30 AM ET
    0129: Real-World Flare Rates and Progression by Treatment Settings Among the Commercially-Insured Systemic Lupus Erythematosus Population in the U.S

    Abstract Poster Presenter: Sze-jung Wu, PhD – AstraZeneca

  • 8:30 AM – 10:30 AM ET
    0147: A Qualitative Analysis of Methotrexate Self-Injection Education Videos on YouTube: An Update

    Abstract Poster Presenter: Amy Semaka, -None- – University of Alberta

  • 8:30 AM – 10:30 AM ET
    0148: Implementation of an Interprofessional Safety Check to Screen for Latent Tuberculosis at an Academic Tertiary Referral Rheumatology Clinic Increased Screening Rates Compared to Historical Levels

    Abstract Poster Presenter: Meera Subash, MD – University of Texas Health Science Center at Houston

  • 8:30 AM – 10:30 AM ET
    0130: Clinical and Economic Characterization of Systemic Lupus Erythematosus Patients: Real World Observation Across Disease Severity and Payer Channels in the U.S

    Abstract Poster Presenter: Joseph Tkacz, MS – IBM Watson Health

  • 8:30 AM – 10:30 AM ET
    0131: Association of Numeracy with Medication Non-Adherence in Systemic Lupus Erythematosus

    Abstract Poster Presenter: Mithu Maheswaranathan, MD – Duke

  • 8:30 AM – 10:30 AM ET
    0132: Hospitalization Rates Among Patients with Systemic Lupus Erythematosus: A Population Based Study

    Abstract Poster Presenter: Jesse Dabit, MD – Mayo clinic

  • 8:30 AM – 10:30 AM ET
    0133: Cervical Cancer Screening Rate in Women with Systemic Lupus Erythematosus

    Abstract Poster Presenter: Erica Rosen, DO – University of Kansas

  • 8:30 AM – 10:30 AM ET
    0134: Systemic Lupus Erythematosus Is a Risk Factor for Mortality in Older Patients with Early-Stage Breast Cancer

    Abstract Poster Presenter: Sebastian Bruera, MD, BS – Baylor College of Medicine

  • 8:30 AM – 10:30 AM ET
    0135: Comparing Rheumatoid Arthritis (RA), Psoriatic Arthritis (PA) and Systemic Lupus Erythematosus (SLE) Total Cost of Care (TCC) in Those with Optimally Managed Depression to Those with Sub-optimally Managed Depression

    Abstract Poster Presenter: Joseph Couto, PharmD, MBA – CVS Health

  • 8:30 AM – 10:30 AM ET
    0136: Underutilization of Mental Health Services in a Busy Tertiary Care Rheumatology Facility

    Abstract Poster Presenter: David Lim, DO – Loma Linda University Health

  • 8:30 AM – 10:30 AM ET
    Imaging of Rheumatic Diseases Poster (0149–0182)
  • 8:30 AM – 10:30 AM ET
    0149: Development of Joint Effusion, Hyperperfusion and Enthesitis After One Hour of Age-and Gender Adjusted Weight Training

    Abstract Poster Presenter: Valentin Schäfer, MD, PhD – University Hospital Bonn

  • 8:30 AM – 10:30 AM ET
    0150: Clinical Characteristics and Quantitative CT Findings in Connective Tissue Disease-Associated Interstitial Lung Disease

    Abstract Poster Presenter: Sirus Jesudasen, MD – Massachusetts General Hospital

  • 8:30 AM – 10:30 AM ET
    0151: Usefulness of Ultrasound and (FDG) PET/CT to Detect Cranial and Extracranial Artery Involvement in Patients with Suspected Large Vessel Vasculitis

    Abstract Poster Presenter: Juan Molina Collada, MD – Hospital General Universitario Gregorio Marañón

  • 8:30 AM – 10:30 AM ET
    0152: Deep Learning-Derived Chest Radiograph Scores in COVID-19 in Rheumatic Disease Patients versus General Population Comparators

    Abstract Poster Presenter: Naomi J. Patel, MD – Massachusetts General Hospital

  • 8:30 AM – 10:30 AM ET
    0153: Echogenic and Hypervascular Synovium Detected on Ultrasound Are Predictive of a Favorable Response After Intra-articular Corticosteroid Injection in Patients with Knee Osteoarthritis

    Abstract Poster Presenter: Robert Dima, BSc – University of Western Ontario

  • 8:30 AM – 10:30 AM ET
    0154: Utilization of Magnetic Resonance Imaging in Early Rheumatoid Arthritis: Results from a Population-based Cohort (1999-2014)

    Abstract Poster Presenter: Caitrin M. Coffey, MD – Mayo Clinic

  • 8:30 AM – 10:30 AM ET
    0155: The Additional Value of MRI in Diagnosis of Rheumatoid Arthritis in Undifferentiated Arthritis Patients

    Abstract Poster Presenter: Nikolet K. den Hollander, MD – Leids Universitair Medisch Centrum

  • 8:30 AM – 10:30 AM ET
    0156: Tenosynovitis Detected by Power Doppler Ultrasound: A Differential Feature of Patients with Seronegative Rheumatoid Arthritis

    Abstract Poster Presenter: Einer Sanchez Prado, MD – Hospital Italiano La Plata

  • 8:30 AM – 10:30 AM ET
    0157: Development of a Deep Learning Algorithm for the Detection of Sacroiliitis on MRI in Patients with Active Axial Spondyloarthritis

    Abstract Poster Presenter: Joeri Nicolaes, MSc – UCB Pharma

  • 8:30 AM – 10:30 AM ET
    0158: The Influence of Age on the Prevalence of Inflammatory and Post-inflammatory MRI Lesions in the Sacroiliac Joints of Patients with and Without Axial Spondyloarthritis

    Abstract Poster Presenter: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne

  • 8:30 AM – 10:30 AM ET
    0159: Structural Damage in Axial Spondyloarthritis: Is There a Preferred Way to Assess Progression over Time?

    Abstract Poster Presenter: Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne

  • 8:30 AM – 10:30 AM ET
    0160: Identifying Erosive Disease from Radiology Reports of Veterans with Inflammatory Arthritis with Natural Language Processing

    Abstract Poster Presenter: Gopi Penmetsa, MD – University of Utah

  • 8:30 AM – 10:30 AM ET
    0161: Does 18F-FDG-PET/MRI Add Metabolic Information to Anatomic Image in Childhood-onset Takayasu’s Arteritis Patients? A Multicenter Case Series

    Abstract Poster Presenter: Gleice Clemente, PhD – Universidade Federal de Sao Paulo

  • 8:30 AM – 10:30 AM ET
    0162: Cardiac Magnetic Resonance Imaging for Guiding Decision-making on Treatment Duration: Data from RHAPSODY, a Phase 3 Clinical Trial of Rilonacept in Recurrent Pericarditis

    Abstract Poster Presenter: Paul Cremer, MD – Department of Cardiovascular Imaging, Center for the Diagnosis and Treatment of Pericardial Diseases, Heart and Vascular Institute, Cleveland Clinic

  • 8:30 AM – 10:30 AM ET
    0163: Diagnosis of Giant Cell Arteritis in Spain: Data from the ARTESER Registry

    Abstract Poster Presenter: Eugenio De Miguel, MD, PhD – Hospital Universitario La Paz

  • 8:30 AM – 10:30 AM ET
    0164: Disrupted Executive Control Network Structural-Functional Integration Is Associated with Inferior Performance of Cognitive Switching Tasks in Patients with Systemic Lupus Erythematosus (SLE)

    Abstract Poster Presenter: Anselm Mak, MD;PhD;MBBS;FRCP – National University of Singapore

  • 8:30 AM – 10:30 AM ET
    0165: Shear-Wave Elastography Evaluation of Major Salivary Glands and Correlation with B-mode Findings in Patients with Primary Sjögren’s Syndrome

    Abstract Poster Presenter: Ana R. Prata, MD – Centro Hospitalar e Universitário de Coimbra

  • 8:30 AM – 10:30 AM ET
    0166: Digital Extensor Paratenonitis Is Frequent in Early Rheumatoid Arthritis

    Abstract Poster Presenter: Maria S. Stoenoiu, MD, PhD, RhMSUS – Cliniques Universitaires Saint-Luc

  • 8:30 AM – 10:30 AM ET
    0167: Reliability of a Novel Pediatric Joint-Specific Scoring System for the Elbow, Wrist and Finger Joints

    Abstract Poster Presenter: Patricia Vega-Fernandez, MD – Cincinnati Children's Hospital Medical Center

  • 8:30 AM – 10:30 AM ET
    0168: A Crowdsourcing Approach to Develop Machine Learning Models to Quantify Radiographic Joint Damage in Rheumatoid Arthritis

    Abstract Poster Presenter: Dongmei Sun, PhD – University of Alabama at Birmingham

  • 8:30 AM – 10:30 AM ET
    0169: Ultrasonography of Auricular Cartilage Is a Useful Tool for Diagnosing and Monitoring Disease Activity in Relapsing Polychondritis

    Abstract Poster Presenter: Yoshinori Taniguchi, MD, PhD – Kochi Medical School Hospital

  • 8:30 AM – 10:30 AM ET
    0170: Direct and Conditional Effects of Epicardial Adipose Tissue Volume on Coronary Plaque Progression in Rheumatoid Arthritis

    Abstract Poster Presenter: George A. Karpouzas, MD – Harbor-UCLA Medical Center

  • 8:30 AM – 10:30 AM ET
    0171: Bone Erosions and Osteophytes in Premenopausal Women with Long-standing Rheumatoid Arthritis: Association with Systemic Bone Involvement Using HR-pQCT

    Abstract Poster Presenter: Mariana Perez, MD, PhD – Rheumatology Division, University of Sao Paulo

  • 8:30 AM – 10:30 AM ET
    0172: Assessing Relevant Joints for Monitoring CPPD Diseases: A Systematic Literature Review of Imaging Techniques by the OMERACT Ultrasound – CPPD Subgroup

    Abstract Poster Presenter: Antonella Adinolfi, MD – Rheumatology Unit, Grande Ospedale Metropolitano Niguarda

  • 8:30 AM – 10:30 AM ET
    0173: Greater High-density Lipoprotein Levels over Time Are Linked to Lower Coronary Plaque Formation, Regression and Stabilization of High-risk Lesions in Rheumatoid Arthritis

    Abstract Poster Presenter: George A. Karpouzas, MD – Harbor-UCLA Medical Center

  • 8:30 AM – 10:30 AM ET
    0174: Imaging Neoangiogenesis in Rheumatoid Arthritis II (INIRA II): Whole-body Synovial Uptake of 99mTc-Maraciclatide Correlates with Power Doppler Ultrasound and Serum Neoangiogenic Biomarkers

    Abstract Poster Presenter: Laura Attipoe, MBBS – Kingston Hospital, London

  • 8:30 AM – 10:30 AM ET
    0175: Correlation of Subclinical Synovitis with Juvenile Idiopathic Arthritis Outcome Measurements

    Abstract Poster Presenter: Patricia Vega-Fernandez, MD – Cincinnati Children's Hospital Medical Center

  • 8:30 AM – 10:30 AM ET
    0176: Semi-quantitative Chest Computed Tomography (CT) Analysis in Pediatric Rheumatologic (PR) Patients with Diffuse Lung Disease

    Abstract Poster Presenter: Michal Cidon, MD – CHLA

  • 8:30 AM – 10:30 AM ET
    0177: Dual-Energy Computed Tomography Three Material Decomposition Improves the Sensitivity of Gout Detection

    Abstract Poster Presenter: Justin Tse, PhD – University of Calgary, Cumming School of Medicine

  • 8:30 AM – 10:30 AM ET
    0178: Abdominal Obesity May Confound Accuracy of Cardiovascular Risk Prediction in Rheumatoid Arthritis; Can Coronary Atherosclerosis Imaging and Biomarkers Help?

    Abstract Poster Presenter: George A. Karpouzas, MD – Harbor-UCLA Medical Center

  • 8:30 AM – 10:30 AM ET
    0179: Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Tomography Imaging Predicts Adverse Events in Patients with Autoimmune Rheumatic Disease

    Abstract Poster Presenter: Attila Feher – Yale University School of Medicine - New Haven, CT

  • 8:30 AM – 10:30 AM ET
    0180: Impaired Myocardial Flow Reserve on 82Rubidium Positron Emission Computed Tomography in Patients with Systemic Sclerosis

    Abstract Poster Presenter: Attila Feher – Yale University School of Medicine - New Haven, CT

  • 8:30 AM – 10:30 AM ET
    0181: Magnetic Resonance Imaging Findings in Early Rheumatoid Arthritis: Are There Differences Based on Autoantibody Status?

    Abstract Poster Presenter: Caitrin M. Coffey, MD – Mayo Clinic

  • 8:30 AM – 10:30 AM ET
    0182: Tenderness and Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis

    Abstract Poster Presenter: Irina Gessl, Dr. med. univ. – Medical University of Vienna

  • 8:30 AM – 10:30 AM ET
    Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)
  • 8:30 AM – 10:30 AM ET
    0183: Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 24-Week Results from the Phase 3, Randomized, Double-blind Clinical Trial for CsDMARD-IR and Bio-IR Patients

    Abstract Poster Presenter: Merav Lidar, MD – Chaim Sheba Medical Center

  • 8:30 AM – 10:30 AM ET
    0192: Influence of Canakinumab Dosing on Efficacy and Safety of Long-term Treatment in Patients with Familial Mediterranean Fever - Interim Analysis of the RELIANCE Registry

    Abstract Poster Presenter: Jorg Henes, MD – University Hospital Tuebingen

  • 8:30 AM – 10:30 AM ET
    0193: Tocilizumab for the Treatment of Familial Mediterranean Fever – a Randomized, Double Blind, Placebo-controlled Phase II Study

    Abstract Poster Presenter: Jorg Henes, MD – University Hospital Tuebingen

  • 8:30 AM – 10:30 AM ET
    0194: Eye Opening: Use of IL-6 Inhibition in Non-Paraneoplastic Autoimmune Retinopathy

    Abstract Poster Presenter: Lisa Carnago, FNP-C – Duke Health

  • 8:30 AM – 10:30 AM ET
    0195: JAK Inhibitors in Refractory Adult and Childhood-Onset Still's Disease

    Abstract Poster Presenter: Louise GILLARD, MD – HOPITAL PITIE SALPETRIERE

  • 8:30 AM – 10:30 AM ET
    0196: A Single Center, Double Blind, Randomized, Placebo-Controlled Trial of Anakinra in Adult Patients with Features of Cytokine Storm Syndrome in COVID-19

    Abstract Poster Presenter: Lesley Jackson, MD – University of Alabama at Birmingham

  • 8:30 AM – 10:30 AM ET
    0197: Successful Treatment of Severe COVID-19 Pneumonia with Simultaneous Tocilizumab and Anakinra - A Case Series

    Abstract Poster Presenter: Hildrun Haibel, PhD – Charité University Medicine Berlin Campus Benjamin Franklin

  • 8:30 AM – 10:30 AM ET
    0198: High Dose Intravenous Methylprednisolone Induces Rapid Improvement of Visual Acuity in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases

    Abstract Poster Presenter: Nuria Vegas Revenga, MD – Hospital Galdakao- Usansolo

  • 8:30 AM – 10:30 AM ET
    0199: Rapid Improvement in Cystoid Macular Edema with High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases

    Abstract Poster Presenter: Nuria Vegas Revenga, MD – Hospital Galdakao- Usansolo

  • 8:30 AM – 10:30 AM ET
    0200: In Undifferentiated Arthritis, DMARD-treatment Intensified During the Last Decennia but Did Not Result in Improved Outcomes

    Abstract Poster Presenter: Marloes Verstappen, MD – Leiden University Medical Center

  • 8:30 AM – 10:30 AM ET
    0201: Australian Psoriatic Arthritis (PsA) Biologic Disease-modifying Antirheumatic Drug (bDMARD) Treatment Pathways Using Sankey Diagrams and Predictive Analysis: A Combined Australian Rheumatology Association Database (ARAD) and Pharmaceutical Benefits Scheme (PBS) Analysis

    Abstract Poster Presenter: Ashley Fletcher – Cabrini Health

  • 8:30 AM – 10:30 AM ET
    0184: Phase III, Randomized Trial Comparing Clinical Outcomes Between Patients with Moderate-to-severe Chronic Plaque Psoriasis Receiving Adalimumab Reference Product (RP) Continuously versus Those Who Switched Between BI 695501 and Adalimumab RP

    Abstract Poster Presenter: Alan Menter, MD – Baylor Scott & White

  • 8:30 AM – 10:30 AM ET
    0202: Variables Associated with Response to Therapy in Patients with Interstitial Pneumonia with Autoimmune Features

    Abstract Poster Presenter: Elena Joerns, MD – UT Southwestern

  • 8:30 AM – 10:30 AM ET
    0203: Chemoprophylaxis in Latent Tuberculosis Associated with Rheumatic Immune-mediated Diseases. Study of 240 Patients from a Single University Hospital

    Abstract Poster Presenter: David Martinez-Lopez, MD – Hospital Universitario Marqués de Valdecilla

  • 8:30 AM – 10:30 AM ET
    0204: Risk of Hepatitis B Virus Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics After Prophylactic Anti-viral Agents

    Abstract Poster Presenter: Soo Min Ahn, MD – ASAN MEDICAL CENTER

  • 8:30 AM – 10:30 AM ET
    0205: An Observational Study from the Perspective of Rheumatology in the Management of Patients with Psoriatic Arthritis in Turkey – LOOP Study

    Abstract Poster Presenter: Ediz Dalkilic, MD, PhD – Uludag University, School of Medicine – Bursa, Turkey

  • 8:30 AM – 10:30 AM ET
    0206: Hydroxycloroquine-Induced Atrioventricular Block in Inmune-Mediated Diseases. Single University Center Study of 293 Patients

    Abstract Poster Presenter: Alba Herrero-Morant, MD – Hospital Universitario Marqués de Valdecilla

  • 8:30 AM – 10:30 AM ET
    0207: Treatment of Ocular Sarcoidosis: Study of 65 Patients of a Series of 384 Patients from a Single University Hospital

    Abstract Poster Presenter: Carmen Álvarez-Reguera, MD – Hospital Universitario Marqués de Valdecilla

  • 8:30 AM – 10:30 AM ET
    0208: Musculoskeletal Immune-Related Adverse Effects of Immune Checkpoint Inhibitors at a Single Site in a Hispanic Population in Puerto Rico

    Abstract Poster Presenter: Adianez Santiago, MD – Department of Medicine, Division of Rheumatology, Allergy and Immunology; University of Puerto Rico-School of Medicine

  • 8:30 AM – 10:30 AM ET
    0209: IgG4 Related Disease: Response to Immunosuppressive Therapy - A Single Centre Retrospective Study in the United Kingdom

    Abstract Poster Presenter: Shirish Sangle, MD;MBBS – Guy's and St Thomas' Hospital NHS Trust

  • 8:30 AM – 10:30 AM ET
    0185: Phase 1 Study Results of GS-5718, an Oral IRAK4-Inhibitor: Pharmacodynamics of Single and Multiple Doses of GS-5718 in Healthy Subjects

    Abstract Poster Presenter: Silke Roedder, PhD, PharmD – Gilead Sciences

  • 8:30 AM – 10:30 AM ET
    0186: Continued Treatment with Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-Related Interstitial Lung Diseases: Data from INBUILD-ON

    Abstract Poster Presenter: Eric L. Matteson, MD, MPH – Prof. Eric Matteson

  • 8:30 AM – 10:30 AM ET
    0187: Safety and Tolerability of Nintedanib in Patients with Autoimmune Disease-Related Interstitial Lung Diseases: Pooled Data from the SENSCIS and INBUILD Trials

    Abstract Poster Presenter: Vanessa Smith, -None- – Ghent University Hospital

  • 8:30 AM – 10:30 AM ET
    0188: Effect of Nintedanib on Categorical Changes in FVC in Patients with Progressive Fibrosing ILDs: Further Analyses of the INBUILD Trial

    Abstract Poster Presenter: Toby Maher, MD – Royal Brompton Hospital

  • 8:30 AM – 10:30 AM ET
    0189: Tapering and Discontinuation of Background Therapies During the Transition to Rilonacept Monotherapy in RHAPSODY, a Phase 3 Clinical Trial of Rilonacept in Patients with Recurrent Pericarditis

    Abstract Poster Presenter: Antonio Brucato, MD – Department of Biomedical and Clinical Science, University of Milano, Fatebenefratelli Hospital

  • 8:30 AM – 10:30 AM ET
    0190: Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry

    Abstract Poster Presenter: Jasmin Kuemmerle-Deschner, MD – Pediatric Rheumatology and Autoinflammatory Reference Center, University Children's Hospital Tuebingen

  • 8:30 AM – 10:30 AM ET
    0191: Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS) - 30-months Interim Analysis of the RELIANCE Registry

    Abstract Poster Presenter: Jasmin Kuemmerle-Deschner, MD – Pediatric Rheumatology and Autoinflammatory Reference Center, University Children's Hospital Tuebingen

  • 8:30 AM – 10:30 AM ET
    Osteoarthritis – Clinical Poster I (0210–0224)
  • 8:30 AM – 10:30 AM ET
    0210: Using Machine Learning to Predict Medial Knee Cartilage Worsening over 2 Years Using Gait and Physical Activity: The MOST Study

    Abstract Poster Presenter: Kerry E. Costello, PhD – Boston University

  • 8:30 AM – 10:30 AM ET
    0219: Intra-Articular Mineralization on Knee CT and Risk of Cartilage Loss: The Multicenter Osteoarthritis Study

    Abstract Poster Presenter: Jean W. Liew, MD, MS – Boston University

  • 8:30 AM – 10:30 AM ET
    0220: Relation of Knee Extensor Power to Worsening Cartilage Damage in the Knee: The MOST Study

    Abstract Poster Presenter: Joshua J. Stefanik, MSPT, PhD – Northeastern University

  • 8:30 AM – 10:30 AM ET
    0221: Trunk Movement Compensation Is Associated with Physical Performance Measures and Fatigue Deficits in Hip Osteoarthritis

    Abstract Poster Presenter: David Quammen, MS – University of Utah

  • 8:30 AM – 10:30 AM ET
    0222: Effects of Multi-Joint Osteoarthritis Phenotypes on Self-Reported Physical Function over 3.5 Years: The Johnston County Osteoarthritis Project

    Abstract Poster Presenter: Amanda E. Nelson, MD, MS, RhMSUS – University of North Carolina at Chapel Hill

  • 8:30 AM – 10:30 AM ET
    0223: The Association of Clinical and Structural Knee Osteoarthritis with Physical Activity in the Middle-aged Population: The Netherlands Epidemiology of Obesity Study

    Abstract Poster Presenter: Sietse Terpstra, n/a – Leiden University Medical Center

  • 8:30 AM – 10:30 AM ET
    0224: Effects of Kinesiophobia and Physical Function on Physical Activity in Adults with Knee Osteoarthritis

    Abstract Poster Presenter: Burcu Aydemir, MS – University of Illinois at Chicago

  • 8:30 AM – 10:30 AM ET
    0211: Unsupervised Machine-learning Algorithms for the Identification of Clinical Phenotypes in the Osteoarthritis Initiative Database

    Abstract Poster Presenter: Philip G. Conaghan, PhD, MBBS – University of Leeds

  • 8:30 AM – 10:30 AM ET
    0212: Unsupervised Clustering of Histology and Ultrasound Scores Identifies Osteoarthritis Subtypes

    Abstract Poster Presenter: Maxwell Konnaris, BS – Hospital or Special Surgery

  • 8:30 AM – 10:30 AM ET
    0213: Quantitative Assessment of Volumetric Change in Hip Effusion Using Artificial Intelligence in Patients with Osteoarthritis of the Hip

    Abstract Poster Presenter: Banafshe Felfeliyan, MSc – University of Calgary

  • 8:30 AM – 10:30 AM ET
    0214: Baseline Cam or Pincer Morphology Is Associated with Loss of Quantitative Joint Space Width at the Hip: The Johnston County Osteoarthritis Project

    Abstract Poster Presenter: Amanda E. Nelson, MD, MS, RhMSUS – University of North Carolina at Chapel Hill

  • 8:30 AM – 10:30 AM ET
    0215: Ultrasonographic Assessment of Knee Osteoarthritis and Its Agreement with Radiography

    Abstract Poster Presenter: KHOA D. NGUYEN, MD, PhD – Cho Ray Hospital

  • 8:30 AM – 10:30 AM ET
    0216: Distribution of Medial Femur and Tibia Cartilage Volume Change over 48 Months on MRI: Comparison Among Kellgren-Lawrence Grades

    Abstract Poster Presenter: Rebecca Amesbury – Brigham and Women's Hospital

  • 8:30 AM – 10:30 AM ET
    0217: The OMERACT Knee Inflammation MRI Scoring System: Validation of Quantitative Methodologies and Tri-compartmental Overlays by Comparison with the MRI Osteoarthritis Knee Score

    Abstract Poster Presenter: Walter P P. Maksymowych, MD – University of Alberta

  • 8:30 AM – 10:30 AM ET
    0218: Synovitis Does Not Mediate the Relationship Between Body Mass Index and Progression of Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative

    Abstract Poster Presenter: Marina Banuls, PhD – University of San Diego, California; University of Valencia, Spain

  • 8:30 AM – 10:30 AM ET
    Patient Outcomes, Preferences, & Attitudes Poster I: Impact (0225–0240)
  • 8:30 AM – 10:30 AM ET
    0225: Prevalence of Sexual Dysfunction and Depression in German Patients with Psoriasis and Psoriatic Arthritis – Results of the PIPPA Study

    Abstract Poster Presenter: Sebastian Jonas Saur, MD – University Hospital Tuebingen

  • 8:30 AM – 10:30 AM ET
    0226: High Efficacy, Safety, and Tolerability of Secukinumab Injection with 2 mL Auto-injector (300 Mg) in Adult Patients with Moderate to Severe Plaque Psoriasis: 52-week Results from MATURE, a Randomised, Placebo-controlled Trial

    Abstract Poster Presenter: Jacek Szepietowski, MD, PhD, FRCP (Edin) – Department of Dermatology, Venereology and Allergology, Wroclaw Medical University

  • 8:30 AM – 10:30 AM ET
    0227: Work Participation Is Impaired Months Before Clinical Arthritis Is Apparent

    Abstract Poster Presenter: Cleo Rogier, MD – Erasmus MC

  • 8:30 AM – 10:30 AM ET
    0228: Optimizing Social Media as a Recruitment Tool for Hard-to-Reach Populations in Rheumatology Clinical Research

    Abstract Poster Presenter: Vlad Tsaltskan, MD – University of California San Diego

  • 8:30 AM – 10:30 AM ET
    0229: The Effects of Self-efficacy on Fatigue and Pain Interference in Black Women with Systemic Lupus Erythematosus: The Role of Depression, Age, and Education

    Abstract Poster Presenter: Cristina Drenkard, MD, PhD – Emory University

  • 8:30 AM – 10:30 AM ET
    0230: Fatigue and Inflammation in Rheumatoid Arthritis Are Already Disconnected Before Clinical Arthritis Develops

    Abstract Poster Presenter: Sarah Khidir, MD, PhD – Leiden University Medical Center

  • 8:30 AM – 10:30 AM ET
    0231: Reducing the Number of Outpatient Clinic Visits by Using the Routine Assessment of Patient Index Data 3 as a Screening Tool

    Abstract Poster Presenter: Jimmy Wiegel, MD – Reade

  • 8:30 AM – 10:30 AM ET
    0232: The Impact of Deucravacitinib on Health-Related Quality of Life Measured by the Short Form Health Survey 36-Item Questionnaire: Analysis of a Phase 2 Trial in Patients with Active PsA

    Abstract Poster Presenter: Vibeke Strand, MD – Stanford University School of Medicine

  • 8:30 AM – 10:30 AM ET
    0233: Feasibility and Acceptability of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change

    Abstract Poster Presenter: Melissa French, MS – Lupus Foundation of America

  • 8:30 AM – 10:30 AM ET
    0234: Impact of Early Pain Improvement on Patient-reported Outcomes in Patients with Psoriatic Arthritis: Results from a Phase 3 Trial

    Abstract Poster Presenter: Louis Bessette, MD, MSc – Centre de l'Ostéoporose et de Rhumatologie de Québec

  • 8:30 AM – 10:30 AM ET
    0235: Are Comorbidities in Patients with Chronic Inflammatory Rheumatic Diseases Associated with Treatment Adherence to Biosimilars in a Non-medical Switch Scenario?

    Abstract Poster Presenter: Uta Kiltz, PhD – Rheumazentrum Ruhrgebiet

  • 8:30 AM – 10:30 AM ET
    0236: Maternal Attachment, Anxiety and Depressive Symptoms in Pregnant Women with Rheumatic Diseases

    Abstract Poster Presenter: Luis Espinosa-Banuelos, MD – Faculty of Medicine and University Hospital Dr. Jose Eleuterio Gonzalez, UANL

  • 8:30 AM – 10:30 AM ET
    0237: Self-perceived General Health at Start of Anti-TNF Therapy Predicts Therapeutic Response in Patients with Rheumatoid Arthritis: Analysis from the Czech Biologics Registry ATTRA

    Abstract Poster Presenter: Jakub Zavada, n/a – Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University

  • 8:30 AM – 10:30 AM ET
    0238: The Impact of Preeclampsia on Pregnancies and Infants of Women with Rheumatic Disease

    Abstract Poster Presenter: Megan Milne, MD – Duke University

  • 8:30 AM – 10:30 AM ET
    0239: Work Disability Associated with Fatigue in Patients with Psoriatic Arthritis – a Retrospective Study Using Claims Data, 2009-2019

    Abstract Poster Presenter: Elaine Husni, MD, MPH – Cleveland Clinic

  • 8:30 AM – 10:30 AM ET
    0240: Economic Burden of Fatigue Among Patients with Psoriatic Arthritis – a Retrospective Study Using Claims Data, 2009-2019

    Abstract Poster Presenter: Joseph F. Merola, MD – Brigham and Women’s Hospital, Harvard Medical School

  • 8:30 AM – 10:30 AM ET
    Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)
  • 8:30 AM – 10:30 AM ET
    0242: FiRst Line Options for Systemic JIA Treatment (FROST): Results from a Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Consensus Treatment Plan Observational Study

    Abstract Poster Presenter: Timothy Beukelman, MD, MSCE – University of Alabama at Birmingham

  • 8:30 AM – 10:30 AM ET
    0244: Development of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration

    Abstract Poster Presenter: Pamela Weiss, MD, MSCE – Children's Hospital of Philadelphia

  • 8:30 AM – 10:30 AM ET
    0246: Macrophage Activating Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Biological Drugs

    Abstract Poster Presenter: Betul Sozeri, MD PhD – University of Health Sciences, Umraniye Tranining and Research Hospital Division of Pediatric Rheumatology

  • 8:30 AM – 10:30 AM ET
    0248: Proportion of Patients with a Polyphasic Disease Course in Systemic-onset Juvenile Idiopathic Arthritis May Be Higher in the Age of Cytokine Inhibitors

    Abstract Poster Presenter: Itay Marmor, MD – Washington University in St. Louis

  • 8:30 AM – 10:30 AM ET
    0250: Is There a Need for a New Classification Criteria in Juvenile Spondyloarthritis?

    Abstract Poster Presenter: Maria Katsicas, MD – Hospital Garrahan

  • 8:30 AM – 10:30 AM ET
    0252: Role of Clinical and Laboratory Parameters in Differentiating Infection from Disease Flare in Febrile Patients of Systemic Juvenile Idiopathic Arthritis

    Abstract Poster Presenter: Rajesh Kanumuri, MD, DM – Amrita Institute of Medical Sciences

  • 8:30 AM – 10:30 AM ET
    0254: Patient and Disease-Level Factors Associated with Sustained Cessation of Medication for Disease Remission in Systemic Juvenile Idiopathic Arthritis

    Abstract Poster Presenter: Elaine Flanagan, MD – Emory University

  • 8:30 AM – 10:30 AM ET
    0241: Psoriasis Rate Is Increased by the Exposure to TNF Inhibition in Children with JIA

    Abstract Poster Presenter: Yongdong (Dan) Zhao, MD, PhD – University of Washington

  • 8:30 AM – 10:30 AM ET
    0257: Can We Assess Disability in Juvenile Idiopathic Arthritis with Two Simple Questions? Results from the CAPRI Registry

    Abstract Poster Presenter: Meghan McPherson, MD – University of Manitoba

  • 8:30 AM – 10:30 AM ET
    0258: Developing Electronic Health Record Algorithms That Accurately Identify Patients with Juvenile Idiopathic Arthritis

    Abstract Poster Presenter: Hannah Peterson, PharmD – Lipscomb University College of Pharmacy

  • 8:30 AM – 10:30 AM ET
    0259: JIA Diagnoses and Trends from 2006-2019: Has the U.S. ICD-9-to-ICD-10 Transition Created Coding Artifacts?

    Abstract Poster Presenter: Daniel B. Horton, MD, MS – Rutgers Robert Wood Johnson Medical School

  • 8:30 AM – 10:30 AM ET
    0260: Impact on Caregivers of Patients with Juvenile Idiopathic Arthritis: A Hospital-based Study from India

    Abstract Poster Presenter: Anu Balakrishnan, MD – SGPGI

  • 8:30 AM – 10:30 AM ET
    0261: Methotrexate Withdrawal and Outcomes in Participants with Well-controlled Non-systemic JIA Within the CARRA Registry

    Abstract Poster Presenter: Marinka Twilt, MD, PhD, MSc – Alberta Children's Hospital

  • 8:30 AM – 10:30 AM ET
    0262: High Degree of Inter-patient Heterogeneity in Synoviocyte Hyperplasia and Immune Cells Infiltration in the Synovium of Juvenile Idiopathic Arthritis Patients

    Abstract Poster Presenter: Clément Triaille, n/a – Pôle de pathologies rhumatismales systémiques et inflammatoires, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain

  • 8:30 AM – 10:30 AM ET
    0263: Patterns of Medication Switching in Juvenile Idiopathic Arthritis: A Retrospective Analysis of a National Administrative Claims Database

    Abstract Poster Presenter: Mei-Sing Ong, PhD – Harvard Medical School & Harvard Pilgrim Healthcare Institute

  • 8:30 AM – 10:30 AM ET
    0264: Joint Acoustic Emissions as a Biomarker to Differentiate Between Active and Inactive Juvenile Idiopathic Arthritis via 2-stage Machine Learning Classifier

    Abstract Poster Presenter: Luis Rosa, MS – Georgia Institute of Technology

  • 8:30 AM – 10:30 AM ET
    0243: Effectiveness of Abatacept in Patients with JIA, Classified by Category: Results from the PRCSG/PRINTO JIA Real-World Registry

    Abstract Poster Presenter: Daniel Lovell, MD, MPH – Cincinnati Children's Hospital Medical Center

  • 8:30 AM – 10:30 AM ET
    0265: Development and Preliminary Acceptability of JIActiv, a Social Media-Based Program Promoting Engagement in Physical Activity Among Young People Living with Juvenile Idiopathic Arthritis

    Abstract Poster Presenter: Sabrina Cavallo, PhD, OT – Université de Montréal

  • 8:30 AM – 10:30 AM ET
    0245: Long-term Safety and Effectiveness of Abatacept Treatment in Patients with JIA: 5-year Results from the PRCSG/PRINTO JIA Real-World Registry

    Abstract Poster Presenter: Hermine I. Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center

  • 8:30 AM – 10:30 AM ET
    0247: Three-year Effectiveness in Patients with JIA Initiating Abatacept: Results from the PRCSG/PRINTO JIA Real-World Registry

    Abstract Poster Presenter: Nicolino Ruperto, MD, MPH – IRCCS Istituto Giannina Gaslini; PRINTO, Clinica Pediatrica e Reumatologia

  • 8:30 AM – 10:30 AM ET
    0249: Open-label, Long-term (10-year) Study of the Safety of Etanercept in Children with Extended Oligoarticular Arthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis

    Abstract Poster Presenter: Jelena Vojinovic, MD, PhD – University of Nis, Faculty of Medicine

  • 8:30 AM – 10:30 AM ET
    0251: A Comparative Study of the Validity of the DAS28-ESR and JADAS-27 Disease Activity Assessment Indexes for Juvenile Idiopathic Arthritis in Transition and Adults

    Abstract Poster Presenter: Takako Miyamae, MD, PhD. – Tokyo Women's Medical University

  • 8:30 AM – 10:30 AM ET
    0253: Rheumatoid Factor Status as a Predictor of Disease Activity and Disability:An Analysis of the New CARRA Registry Polyarticular Juvenile Idiopathic Arthritis Cohort

    Abstract Poster Presenter: Nayimisha Balmuri, MD – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0255: Identification of Tolerated Disease Activity Level for Individuals with Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry

    Abstract Poster Presenter: Melissa L. Mannion, MD – University of Alabama at Birmingham

  • 8:30 AM – 10:30 AM ET
    0256: Consensus Approach to a Treat to Target Strategy in Juvenile Idiopathic Arthritis Care: Report from the 2020 Pediatric Rheumatology Care and Outcomes Improvement Network Consensus Conference

    Abstract Poster Presenter: Tala El Tal, MD – University of Toronto/Hospital for Sick Children

  • 8:30 AM – 10:30 AM ET
    Psychology/Social Sciences Poster (0266–0267)
  • 8:30 AM – 10:30 AM ET
    0267: Psychosocial and Health Measures in Systemic Lupus Erythematosus: Before and During the COVID-19 Pandemic in the Georgian's Organized Against Lupus Cohort

    Abstract Poster Presenter: Charmayne Dunlop-Thomas, MS, MPH – Emory University

  • 8:30 AM – 10:30 AM ET
    0266: The Psychosocial Impact of the COVID-19 Pandemic on the Rheumatology Patient Experience

    Abstract Poster Presenter: Melissa Flores, MPH, MSW – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)
  • 8:30 AM – 10:30 AM ET
    0295: Weight History and Associations with Cardiovascular Risk in Patients with Rheumatoid Arthritis

    Abstract Poster Presenter: Lydia E. Federico, MA – Perelman School of Medicine at the University of Pennsylvania

  • 8:30 AM – 10:30 AM ET
    0268: Effect of Biologic Agents on Lipids and Cardiovascular Risk in Rheumatoid Arthritis Patients

    Abstract Poster Presenter: Dimitrios A. Pappas, MD, MPH – Columbia University

  • 8:30 AM – 10:30 AM ET
    0269: Autoantibodies and the Risk of Incident Cardiovascular Disease in US Veterans with Rheumatoid Arthritis

    Abstract Poster Presenter: Tate M. Johnson, MD – University of Nebraska Medical Center

  • 8:30 AM – 10:30 AM ET
    0270: Impact of Macrophage Cholesterol Loading Capacity and Interactions with Treatments on Cardiovascular Risk and Coronary Atherosclerosis Burden in Rheumatoid Arthritis

    Abstract Poster Presenter: George A. Karpouzas, MD – Harbor-UCLA Medical Center

  • 8:30 AM – 10:30 AM ET
    0271: Higher Prevalence of Subclinical Atherosclerosis in the First Five Years of Rheumatoid Arthritis Diagnosis

    Abstract Poster Presenter: DIONICIO A. GALARZA DELGADO – UANL

  • 8:30 AM – 10:30 AM ET
    0272: RA Disease Activity Is an Independent Predictor of Left Ventricular Mass Changes in an RA Cohort Without Cardiovascular Disease

    Abstract Poster Presenter: Elizabeth Park, MD – Columbia University Medical Center

  • 8:30 AM – 10:30 AM ET
    0273: Abnormalities in Left Ventricular Geometry Influenced by Higher Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Titers in Rheumatoid Arthritis Patients

    Abstract Poster Presenter: DIONICIO A. GALARZA DELGADO – UANL

  • 8:30 AM – 10:30 AM ET
    0274: Angiopoietin-Like Protein 4, Apolipoprotein C3 and Lipoprotein Lipase Axis in the Abnormal Lipid Profile of Patients with Rheumatoid Arthritis: Relation to Subclinical Atheromatosis

    Abstract Poster Presenter: Ivan Ferraz Amaro, MD – Division of Rheumatology. Hospital Universitario de Canarias. Spain.

  • 8:30 AM – 10:30 AM ET
    0275: Impact of Disease Activity on Left Ventricular Diastolic Dysfunction in Rheumatoid Arthritis Patients

    Abstract Poster Presenter: DIONICIO A. GALARZA DELGADO – UANL

  • 8:30 AM – 10:30 AM ET
    0276: Pulse Pressure as a Predictor of Carotid Plaque in Rheumatoid Arthritis Patients

    Abstract Poster Presenter: Iris J. Colunga, MD, PhD – Hospital Universitario UANL

  • 8:30 AM – 10:30 AM ET
    0277: Best Cardiovascular Risk Algorithm to Predict Abnormalities in Left Ventricular Geometry in Rheumatoid Arthritis Patients

    Abstract Poster Presenter: José Ramón R. Azpiri-López, MD, PhD – Hospital Universitario UANL

  • 8:30 AM – 10:30 AM ET
    0278: Higher Prevalence of Eccentric Hypertrophy in Rheumatoid Arthritis Patients: A Case-Control Study

    Abstract Poster Presenter: José Ramón R. Azpiri-López, MD, PhD – Hospital Universitario UANL

  • 8:30 AM – 10:30 AM ET
    0279: Macrophage Cholesterol Loading Associates with Low-density Lipoprotein Structure, Oxidation, Antibodies Against Oxidized Epitopes and Is Modified by Immunomodulatory Treatments in Patients with Rheumatoid Arthritis

    Abstract Poster Presenter: George A. Karpouzas, MD – Harbor-UCLA Medical Center

  • 8:30 AM – 10:30 AM ET
    0280: Mast Cells Contribute to the Development of Lung Fibrosis via Inducing Myofibroblast Differentiation by TGF-β Production

    Abstract Poster Presenter: Shinjiro Kaieda, MD, PhD – Kurume university School of Medicine

  • 8:30 AM – 10:30 AM ET
    0281: Unsupervised Machine Learning of Expanded Autoantibodies, Cytokines, and Chemokines Improves the Identification of Interstitial Lung Disease in Rheumatoid Arthritis

    Abstract Poster Presenter: Bryant R. England, MD, PhD – University of Nebraska Medical Center

  • 8:30 AM – 10:30 AM ET
    0282: 5-Year Cardiovascular Event Risk in Early Rheumatoid Arthritis Patients Who Received Treat-to-Target Management: A Population-based Cohort Study

    Abstract Poster Presenter: Tsz On Lam, MBBS – Prince of Wales Hospital

  • 8:30 AM – 10:30 AM ET
    0283: Cardiovascular Risk Management in Patients with Rheumatoid Arthritis: A Single-centered Cross-sectional Study

    Abstract Poster Presenter: Samar Aboulenain, MD – University of Toronto

  • 8:30 AM – 10:30 AM ET
    0284: Risk Factors for Dementia in Patients with Incident Rheumatoid Arthritis: A Population-based Cohort Study

    Abstract Poster Presenter: Elena Myasoedova, MD, PhD – Mayo Clinic

  • 8:30 AM – 10:30 AM ET
    0285: Risk of Cardiovascular Disease in Newly Diagnosed Rheumatoid Arthritis: A Current Risk Assessment

    Abstract Poster Presenter: Reinder Raadsen, MD – Reade

  • 8:30 AM – 10:30 AM ET
    0286: Cardiovascular Disease Risk in Inflammatory Arthritis Patients Still Substantially Elevated in 2020

    Abstract Poster Presenter: Reinder Raadsen, MD – Reade

  • 8:30 AM – 10:30 AM ET
    0287: 20 Years Follow-up of Cardiovascular Event Risk in Rheumatoid Arthritis Compared to Diabetes

    Abstract Poster Presenter: Reinder Raadsen, MD – Reade

  • 8:30 AM – 10:30 AM ET
    0288: Demographic, Lifestyle, and Clinical Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies

    Abstract Poster Presenter: Gregory McDermott, MD – Brigham and Women's Hospital

  • 8:30 AM – 10:30 AM ET
    0289: Developing a Score to Predict Preclinical Interstitial Lung Disease in Patients with Rheumatoid Arthritis – a Cross-Sectional Study from the ESPOIR Cohort

    Abstract Poster Presenter: Pierre Antoine Juge, MD, PhD – Hôpital Bichat-Claude Bernard, Service de Rhumatologie

  • 8:30 AM – 10:30 AM ET
    0290: Prevalence and Predictors of Mortality in Rheumatoid Arthritis-Related Lung Disease: Results from a Single Center Study

    Abstract Poster Presenter: Didem Sahin Eroglu, MD – Ankara University Faculty of Medicine

  • 8:30 AM – 10:30 AM ET
    0291: IgA Anti-Cyclic Citrullinated Peptide Antibodies in Bronchoalveolar Lavage Fluid from Patients with Idiopathic Pulmonary Fibrosis Are Associated with Reduced Mortality

    Abstract Poster Presenter: Scott M. Matson, MD – University of Kansas

  • 8:30 AM – 10:30 AM ET
    0292: Suppressed Paraoxonase-1 Activity and Elevated Oxylipins Associate with the Presence of Small Airways Disease in Patients with Rheumatoid Arthritis

    Abstract Poster Presenter: Amir A. Razmjou, MD – UCLA Health

  • 8:30 AM – 10:30 AM ET
    0293: Increased Prevalence of Scleroderma Specific Autoantibodies in Seropositive Rheumatoid Arthritis with Lung Involvement

    Abstract Poster Presenter: Clio P. Mavragani, MD – National and Kapodistrian University of Athens

  • 8:30 AM – 10:30 AM ET
    0294: Comparison of Factors Associated with CT-Scan Progression of Interstitial Lung Disease in Rheumatoid Arthritis and Idiopathic Pulmonary Fibrosis. Retrospective Multicenter Study of 144 Patients

    Abstract Poster Presenter: Charlotte Lucas, n/a – Rheumatology department, University Hospital

  • 8:30 AM – 10:30 AM ET
    RA – Etiology & Pathogenesis Poster (0011–0045)
  • 8:30 AM – 10:30 AM ET
    0011: Differential Inflammation-mediated Function of Prokineticin 2 in the Synovial Fibroblasts of Patients with Rheumatoid Arthritis Compared to Osteoarthritis

    Abstract Poster Presenter: Kentaro Noda, MD, PhD – The Jikei University School of Medicine, Department of Internal Medicine, Division of Rheumatology

  • 8:30 AM – 10:30 AM ET
    0012: A Novel Mechanism Linking Mucosal Bacteria with Autoantibody Responses in RA: Acetylated Bacterial Lysate as a Model Antigen

    Abstract Poster Presenter: Mikhail Volkov, MD – Leiden University Medical Center

  • 8:30 AM – 10:30 AM ET
    0013: Cyclin Dependent Kinase 4 and 6 Determine the Cytokine Responsiveness by Stabilizing JUN in Rheumatoid Arthritis Synovial Fibroblasts

    Abstract Poster Presenter: Tadashi Hosoya, MD, PhD – Tokyo Medical and Dental University(TMDU)

  • 8:30 AM – 10:30 AM ET
    0014: Low Baseline Expression of Pyruvate Kinase and Succinate Dehydrogenase Genes in the Peripheral Blood of Rheumatoid Arthritis Patients Treated with Tofacitinib Is Associated with Clinical Remission at the End of Follow-up

    Abstract Poster Presenter: Elena V. Tchetina, PhD, DSc – Nasonova Research Institute of Rheumatology

  • 8:30 AM – 10:30 AM ET
    0015: Rheumatoid Factor Recognizes Specific Domains of IgG Heavy Chain Complexed with HLA Class II Molecules

    Abstract Poster Presenter: ZHANG SHANSHAN, PhD, -None- – Kyoto University

  • 8:30 AM – 10:30 AM ET
    0016: Structural and Functional Neurobiological Alterations of Salience and Sensorimotor Networks in Juvenile Idiopathic Arthritis

    Abstract Poster Presenter: Hanne van der Heijden, n/a – Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA USA/ Faculty of Psychology and Neuroscience, Section Neuropsychology & Psychopharmacology Maastricht University, Maastricht, The Netherlands/ Faculty of Science, Biomedical Sciences Neurobiology, University of Amsterdam, Amsterdam, The Netherlands

  • 8:30 AM – 10:30 AM ET
    0017: Lessons Learnt from Associations Between Anti-modified Protein Antibodies and Risk Factors: Human Leukocyte Antigen - Shared Epitope Alleles Solely Associate with Anti-citrullinated Protein Antibodies

    Abstract Poster Presenter: Tineke van Wesemael, MSc – LUMC

  • 8:30 AM – 10:30 AM ET
    0018: Caspase-8 Variant G Regulates Rheumatoid Arthritis Fibroblast-Like Synoviocyte Aggressive Behavior

    Abstract Poster Presenter: Cecilia Ansalone, PhD – University of California, San Diego

  • 8:30 AM – 10:30 AM ET
    0019: Increased Circulating CD39+FoxP3+CD4+ Treg Cells in Early Rheumatoid Arthritis Facilitate the Antiinflammatory Action of Methotrexate

    Abstract Poster Presenter: Maria-Eugenia Miranda-Carus, MD, PhD – Hospital La Paz - IdiPAZ

  • 8:30 AM – 10:30 AM ET
    0020: Citrullination Drives the Expression of Pro-fibrotic Genes in Rheumatoid Arthritis Fibroblast-like Cells

    Abstract Poster Presenter: Peter M. Maloley, MD, BS – University of Nebraska Medical Center

  • 8:30 AM – 10:30 AM ET
    0021: Unique Alterations in Circulating T Peripheral Helper Cells Are Found in Different Ethnic Groups of ACPA+ Individuals Both At-risk for and with Classified RA

    Abstract Poster Presenter: Hideto Takada, MD, PhD – Tokyo Women's Medical University

  • 8:30 AM – 10:30 AM ET
    0022: The Effects of MAA-Modified and/or Citrullinated Proteins on Calcium Influx and Peptidyl Arginine Deiminase (PAD) Expression in Macrophage

    Abstract Poster Presenter: Andrew A. Gerber, BA – University of Nebraska Medical Center

  • 8:30 AM – 10:30 AM ET
    0023: Investigating Temporal Changes in Pregnancy Among Women with Rheumatoid Arthritis and Healthy Women Using Co-expression Network Analysis

    Abstract Poster Presenter: Damini Jawaheer, PhD, MS – University of California San Francisco

  • 8:30 AM – 10:30 AM ET
    0024: Heterogeneity of Inflammatory HLA-DR+ Synovial Fibroblasts in Rheumatoid Arthritis Is Driven by Responses to Leukocyte-Derived Cytokines

    Abstract Poster Presenter: Melanie H. Smith, MD, PhD – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0025: The Modulatory Capacity of Galectin-3 on the Programmed Death-1 Signaling Axis in Rheumatoid Arthritis

    Abstract Poster Presenter: Kathrine Pedersen, MS – Aarhus University

  • 8:30 AM – 10:30 AM ET
    0026: Synovial Fibroblasts Acquire a Proinflammatory and Destructive Phenotype After Exposure to αS1-Casein (CSN1S1)

    Abstract Poster Presenter: NADINE HONKE, PhD – Department of Rheumatology, Hiller Research Center

  • 8:30 AM – 10:30 AM ET
    0027: Metabolomic Study of Rheumatoid Arthritis Using 1H Nuclear Magnetic Resonance (1H NMR)

    Abstract Poster Presenter: Konstantina I. Tsezou, BSc, MSc – National and Kapodistrian University of Athens

  • 8:30 AM – 10:30 AM ET
    0028: Evolution of Anti-modified Protein Antibody Responses Can Be Driven by Consecutive Exposure to Different Post-translational Modifications

    Abstract Poster Presenter: Mikhail Volkov, MD – Leiden University Medical Center

  • 8:30 AM – 10:30 AM ET
    0029: JAK1 Regulates Autophagy and Reinforces the Inflammatory and Autoimmune Potentials in Rheumatoid Arthritis Synovial Fibroblasts

    Abstract Poster Presenter: Keita Ninagawa, MD – Hokkaido University

  • 8:30 AM – 10:30 AM ET
    0030: Interleukin-9 Enhances the Osteoclastogenesis in Rheumatoid Arthritis

    Abstract Poster Presenter: Sushmita Chakraborty, n/a – AIIMS

  • 8:30 AM – 10:30 AM ET
    0031: A New Pharmacostatistical Model to Assess MTX-adherence in RA Patients

    Abstract Poster Presenter: Marion Geoffroy, MD – CHU Reims, France

  • 8:30 AM – 10:30 AM ET
    0032: IL-40: A New B-cell Associated Cytokine Up-regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates with Disease Activity, Autoantibodies and NETosis

    Abstract Poster Presenter: Adela Navratilova, n/a – Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University

  • 8:30 AM – 10:30 AM ET
    0033: Impaired Adipose Tissue Function in Rheumatoid Arthritis: Association with Autoimmunity, Disease Activity and Therapeutic Response

    Abstract Poster Presenter: Iván Arias de la Rosa, PhD – University of Cordoba/IMIBIC/Reina Sofia Hospital

  • 8:30 AM – 10:30 AM ET
    0034: Immune Complexes Contain Novel Acetylated Antigens in the Synovial Fluid of RA Patients

    Abstract Poster Presenter: Khetam Ghannam, PhD – Charité Universitätsmedizin Berlin

  • 8:30 AM – 10:30 AM ET
    0035: Bromodomain Protein-regulated Stress Response in Rheumatoid Arthritis Synovial Fibroblasts

    Abstract Poster Presenter: Kerstin Klein, PhD – Department of Rheumatology and Immunology, University Hospital Bern

  • 8:30 AM – 10:30 AM ET
    0036: The NAD+ Metabolism Is Altered in Rheumatoid Arthritis and Its Modulation with NAD+ Boosters Exhibits Key Anti-Inflammatory and Anti-Oxidant Effects

    Abstract Poster Presenter: Carlos Perez-Sanchez, PhD – IMIBIC

  • 8:30 AM – 10:30 AM ET
    0037: Identification and Validation of Four Circulating Autoantibodies Associated with the ACPA Status in Early Rheumatoid Arthritis

    Abstract Poster Presenter: Cristina Ruiz-Romero, PhD – INIBIC - CHUAC

  • 8:30 AM – 10:30 AM ET
    0038: Arthritis Progression in at Risk Individuals Is Associated with ACPAs Not AMPAs

    Abstract Poster Presenter: Alexandra Circiumaru, MD – Division for Rheumatology, Karolinska Institutet; Center for Rheumatology, Academic Specialist Center, Stockholm region

  • 8:30 AM – 10:30 AM ET
    0039: Elevated IgA Subclass Levels in Rheumatoid Arthritis Patients: Indications of a Mucosal Origin?

    Abstract Poster Presenter: Veerle Derksen, MD – Leiden university medical center

  • 8:30 AM – 10:30 AM ET
    0040: M1-M2 Polarization by CTLA4-Ig (Abatacept) on Cultured Circulating Monocytes from Rheumatoid Arthritis Patients and Healthy Subjects

    Abstract Poster Presenter: Maurizio Cutolo, MD – Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Polyclinic San Martino Hospital

  • 8:30 AM – 10:30 AM ET
    0041: Vascularized ‘Synovium-on-a-Chip’ - A Novel and Adaptable Model for Dissecting Inflammatory Biology Underlying Rheumatoid Arthritis

    Abstract Poster Presenter: Theresa Wampler Muskardin, MD – Colton Center for Autoimmunity, NYU School of Medicine

  • 8:30 AM – 10:30 AM ET
    0042: High-throughput Testing for Modified-protein Antibodies in Patients Diagnosed with “Seronegative” Rheumatoid Arthritis

    Abstract Poster Presenter: Michael Richter, MD;MS – University of Washington

  • 8:30 AM – 10:30 AM ET
    0043: Takinib Inhibits IL-1β-Induced Activation of Signal Transducer and Activator of Transcription 3 (STAT3) in Human Rheumatoid Arthritis Synovial Fibroblasts

    Abstract Poster Presenter: Anil K. Singh, PhD – Washington State university

  • 8:30 AM – 10:30 AM ET
    0044: Autoantibodies Against Malondialdehyde-modifications Promote Osteoclast Development by Reprogramming Cellular Metabolism

    Abstract Poster Presenter: Bence Réthi, PhD – Karolinska Institutet and Karolinska University Hospital

  • 8:30 AM – 10:30 AM ET
    0045: Endothelial Cells from Patients with DMARD Naïve, Active Inflammatory Arthritis Demonstrate Pro-inflammatory Sensitisation That Is Reversed by Therapy Initiation

    Abstract Poster Presenter: Robert Maughan, PhD, BSc – Imperial College London

  • 8:30 AM – 10:30 AM ET
    Sjögren's Syndrome – Basic & Clinical Science Poster (0296–0322)
  • 8:30 AM – 10:30 AM ET
    0296: The Impact of Delayed Primary Sjögren’s Syndrome Diagnosis on Patient Outcomes: A Real-World Survey in the US

    Abstract Poster Presenter: Briana Ndife, MPH – Novartis

  • 8:30 AM – 10:30 AM ET
    0305: Artificial Neural Networks Approaches to Predict Myocardial Fibrosis in Primary Sjögren Syndrome Patients Without Cardiac Symptoms

    Abstract Poster Presenter: Hitomi Kobayashi, MD, PhD – Nihon University School of Medicine

  • 8:30 AM – 10:30 AM ET
    0306: Allergic Disorders in Primary Sjögren's Syndrome Compared with Rheumatoid Arthritis

    Abstract Poster Presenter: Misako Higashida-Konishi, MD – Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center

  • 8:30 AM – 10:30 AM ET
    0307: Cerebellar Ataxia in Primary Sjogren’s Syndrome, Is Gluten Sensitivity the Answer?

    Abstract Poster Presenter: Fu Chuen Kon, BSc – University of Sheffield

  • 8:30 AM – 10:30 AM ET
    0308: Sleep Disorders and Serum Brain-derived Neurotrophic Factor Levels in Patients with Primary Sjögren's Syndrome

    Abstract Poster Presenter: Yaxin Han, n/a – 1.The People's Hospital of Wenjiang,China;2.Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China,Chengdu, China;3.Chinese  Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China

  • 8:30 AM – 10:30 AM ET
    0309: Lymphopenia and Leukopenia in Sjogren Syndrome

    Abstract Poster Presenter: Loukas Chatzis, MD – Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens

  • 8:30 AM – 10:30 AM ET
    0310: Histopathology, Salivary Flow and Ultrasonography of the Parotid Gland: Three Complementary Measurements in Primary Sjögren’s Syndrome

    Abstract Poster Presenter: Martha van Ginkel, MD – University Medical Center Groningen, University of Groningen

  • 8:30 AM – 10:30 AM ET
    0311: Ultra High‐frequency Ultrasound (UHFUS) of Labial Glands in Primary Sjögren’s Syndrome: Serological and Histological Correlations

    Abstract Poster Presenter: Giovanni Fulvio, MD – University of Pisa, Rheumatology Unit

  • 8:30 AM – 10:30 AM ET
    0312: Prognostic Value of Salivary Gland Ultrasonography in Primary Sjögren’s Syndrome

    Abstract Poster Presenter: Francesco Ferro, MD – Clinical and Experimental Medicine Department, University of Pisa

  • 8:30 AM – 10:30 AM ET
    0313: Do Primary Sjögren’s Syndrome Patients with Normal Major Salivary Gland Ultrasound Have Less Active Disease?

    Abstract Poster Presenter: Katja Perdan Pirkmajer, MD, PhD – University Medical Centre Ljubljana

  • 8:30 AM – 10:30 AM ET
    0297: Describing the Disease Burden of Primary Sjögren’s Syndrome Patients: Results from a Real-World Survey in the US

    Abstract Poster Presenter: Briana Ndife, MPH – Novartis

  • 8:30 AM – 10:30 AM ET
    0314: PROMIS Provides a Broad Overview of Health-Related Quality of Life in the Evaluation of Sjogren’s Syndrome

    Abstract Poster Presenter: Dana DiRenzo, MD, MHS – University of Pennsylvania

  • 8:30 AM – 10:30 AM ET
    0315: Sjögren’s Syndrome Symptom Diary (SSSD) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) as Assessments of Symptoms in Sjögren’s Syndrome: A Qualitative Exploration of Content Validity and Meaningful Change

    Abstract Poster Presenter: Pushpendra Goswami, n/a – Novartis Pharma AG

  • 8:30 AM – 10:30 AM ET
    0316: Exploring Alternative Responder Definitions for EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) for Use in Sjögren’s Clinical Trials

    Abstract Poster Presenter: Pushpendra Goswami, n/a – Novartis Pharma AG

  • 8:30 AM – 10:30 AM ET
    0317: Patient and Physician Perspectives on EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI) and EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI): A Qualitative Interview Study

    Abstract Poster Presenter: Pushpendra Goswami, n/a – Novartis Pharma AG

  • 8:30 AM – 10:30 AM ET
    0318: Correlation Between Prognostic Nutritional Index and Primary Sjögren's Syndrome Disease Activity

    Abstract Poster Presenter: Kübra Erol Kalkan, MD – TRAKYA UNIVERSITY

  • 8:30 AM – 10:30 AM ET
    0319: Assessment of EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) Domains in Routine Clinical Practice in an Integrated Delivery Network in the United States

    Abstract Poster Presenter: Briana Ndife, MPH – Novartis

  • 8:30 AM – 10:30 AM ET
    0320: Performance of the Clinical Trials ESSDAI (ClinTrialsESSDAI), an Adjusted ESSDAI Score, in Two Randomised Clinical Trials in Patients with Primary Sjögren’s Syndrome

    Abstract Poster Presenter: Liseth de Wolff, MSc – UMCG

  • 8:30 AM – 10:30 AM ET
    0321: Sequential Administration of Belimumab and Rituximab in Primary Sjögren’s Syndrome Reduces Minor Salivary Gland–Resident B Cells and Delays B-Cell Repopulation in Circulation

    Abstract Poster Presenter: Francesca Barone, MD, PhD – University of Birmingham, College of Medical and Dental Sciences

  • 8:30 AM – 10:30 AM ET
    0322: Histopathological Changes in Parotid and Labial Salivary Gland Tissue in Primary Sjögren’s Syndrome Patients After Abatacept Treatment

    Abstract Poster Presenter: Uzma Nakshbandi, MD – University Medical Center Groningen

  • 8:30 AM – 10:30 AM ET
    0298: The Clinical Phenotype of Isolated Ocular and Oral Dryness in Sjogren Syndrome, Fulfilling the 2016 ACR-EULAR Classification Criteria

    Abstract Poster Presenter: Loukas Chatzis, MD – Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens

  • 8:30 AM – 10:30 AM ET
    0299: Sex Hormones and Risk of Sjögren’s Syndrome: Hypothesis Generating Findings Implicating Androgen and Estrogen Ratios

    Abstract Poster Presenter: Sara McCoy, MD, MS – University of Wisconsin

  • 8:30 AM – 10:30 AM ET
    0300: Salivary Gland Epithelial Cells Transcriptomic Analysis Highlight Their Potential Involvement in Extracellular Matrix Modification in Sjögren’s Syndrome

    Abstract Poster Presenter: Elodie Riviere, MD, PhD – INSERM U1184

  • 8:30 AM – 10:30 AM ET
    0301: Activation of Akt Signaling Pathway in the Minor Salivary Glands of Patients with Primary Sjögren’s Syndrome Does Not Relate with Clinical Phenotype

    Abstract Poster Presenter: Loukas Chatzis, MD – Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens

  • 8:30 AM – 10:30 AM ET
    0302: Loss of TAM Receptor Mer Contributes to Sjögren’s Syndrome–like Disease in Mice

    Abstract Poster Presenter: Richard M. Witas, BS – University of Florida

  • 8:30 AM – 10:30 AM ET
    0303: Extraglandular Manifestations as Initial Presentation in a Cohort of Patients with Primary Sjögren's Syndrome

    Abstract Poster Presenter: Lucia Alascio, MD – Hospital Tornú, Ciudad Autónoma de Buenos Aires

  • 8:30 AM – 10:30 AM ET
    0304: Renal Involvement in Sjőgren’s Syndrome: Predictors and Impact on Patient Outcome

    Abstract Poster Presenter: Rudrarpan Chatterjee, MD – Sanjay gandhi Post Graduate Institute of Medical Sciences, Lucknow.

  • 8:30 AM – 10:30 AM ET
    SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)
  • 8:30 AM – 10:30 AM ET
    0323: Ro Positivity Is an Under‐Recognised Poor Prognostic Marker in Systemic Lupus Erythematosus Patients

    Abstract Poster Presenter: Katie Liao, MD – Monash Health

  • 8:30 AM – 10:30 AM ET
    0332: Prevalence of Systemic Lupus Erythematosus in the United States: Updated Population Representative Estimates from the Medical Expenditure Panel Survey (MEPS) 2016-2018

    Abstract Poster Presenter: Shannon C. Grabich, PhD, MS – Xcenda

  • 8:30 AM – 10:30 AM ET
    0333: Validation of the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) Classification Criteria for Systemic Lupus Erythematosus (SLE) in Hong Kong Chinese

    Abstract Poster Presenter: Chi Chiu Mok, MD – Tuen Mun Hospital

  • 8:30 AM – 10:30 AM ET
    0334: Association Between Systemic Lupus Erythematosus and Myasthenia Gravis: A Population-Based National Study

    Abstract Poster Presenter: SALI MERJANAH, MD – Boston University

  • 8:30 AM – 10:30 AM ET
    0335: Performances of Different Classification Criteria for Systemic Lupus Erythematosus in a Single Center Cohort from Turkey

    Abstract Poster Presenter: Ege Sinan Torun, MD – Istanbul University Istanbul Faculty of Medicine

  • 8:30 AM – 10:30 AM ET
    0336: The Incremental Clinical Utility of a Multianalyte Assay Panel with Cell-Bound Complement Activation Products versus a Traditional ANA Testing Strategy for the Diagnosis and Treatment of SLE

    Abstract Poster Presenter: Tyler O'Malley, BSc – Exagen

  • 8:30 AM – 10:30 AM ET
    0337: Rarity of Pneumocystis Jirovecii Pneumonia in Patients with Systemic Lupus Erythematosus Using a Real-world, Electronic Health Record

    Abstract Poster Presenter: Ben Boone, MD – Vanderbilt University Medical Center

  • 8:30 AM – 10:30 AM ET
    0338: Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus

    Abstract Poster Presenter: Safak Mirioglu, MD – Bezmialem Vakif University School of Medicine

  • 8:30 AM – 10:30 AM ET
    0339: Trends in Disparity by Age, Sex and Race for Systemic Lupus Erythematosus Patients

    Abstract Poster Presenter: Anum Akhlaq, MD – Orange Park Medical Center

  • 8:30 AM – 10:30 AM ET
    0340: Urinary L-selectin Predicts Disease Activity and Histological Changes in Lupus Nephritis

    Abstract Poster Presenter: Huihua Ding, MD – Shanghai Jiao Tong University School of Medicine

  • 8:30 AM – 10:30 AM ET
    0341: Addition of Narrative Text Abstraction to ICD-Based Abstraction Significantly Improves Identification of Lupus Nephritis in Real-World Data

    Abstract Poster Presenter: Meghan Tierney, RN, PhD – PicnicHealth

  • 8:30 AM – 10:30 AM ET
    0324: Machine Learning: Identifying Lupus Nephritis Within Systemic Lupus Erythematosus in the Real World

    Abstract Poster Presenter: Bruno C. Teixeira, MSc – Adelphi Real World

  • 8:30 AM – 10:30 AM ET
    0342: RAIL Distinguishes Responder and Non-Responder in Pediatric Lupus Nephritis

    Abstract Poster Presenter: Ellen Cody, MD – Cincinnati Children's Hospital Medical Center

  • 8:30 AM – 10:30 AM ET
    0343: Overview of the Childhood Systemic Lupus Erythematosus (cSLE) Cohort in the CARRA Registry

    Abstract Poster Presenter: Christine Bacha, MD – Nationwide Children's Hospital

  • 8:30 AM – 10:30 AM ET
    0344: Anti-gAChR Antibody as a Novel Biomarker for Lupus Enteritis in Systemic Lupus Erythematosus

    Abstract Poster Presenter: Kuniyuki Aso, MD – Hokkaido University Hospital Internal Medicine II

  • 8:30 AM – 10:30 AM ET
    0345: Anti-MPP-1 Autoantibodies in Systemic Lupus Erythematosus: A Potential Biomarker for Neuropsychiatric Manifestations

    Abstract Poster Presenter: Eugene A. Krustev, MD – University of Calgary

  • 8:30 AM – 10:30 AM ET
    0346: The CB-CAPillaryTM Test Kit: A Tool for Point-of-Care Assays to Measure Cell-Bound Complement Activation Products

    Abstract Poster Presenter: Joseph Ahearn, MD – Allegheny Health Network

  • 8:30 AM – 10:30 AM ET
    0347: Longitudinal ANA Titers in SLE and ANA+ Controls

    Abstract Poster Presenter: Emily Littlejohn, DO, MPH – Cleveland Clinic

  • 8:30 AM – 10:30 AM ET
    0348: The New EULAR/ ACR 2019 SLE Classification Criteria: A Predictor of Long-term Outcomes

    Abstract Poster Presenter: Laura Patricia Whitall Garcia, MD – University Health Network

  • 8:30 AM – 10:30 AM ET
    0349: Performance of the 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in a Predominantly African American Cohort

    Abstract Poster Presenter: Jessica English, MD – Medical University of South Carolina

  • 8:30 AM – 10:30 AM ET
    0350: EPI-SIGN: Epigenetic SLE Indicators of Glomerular Nephritis

    Abstract Poster Presenter: Ashira Blazer, MD – NYU School of Medicine

  • 8:30 AM – 10:30 AM ET
    0351: Gene Signature Fingerprints Divide SLE Patients in Subgroups with Similar Biological Disease Profiles: A Multicenter Longitudinal Study

    Abstract Poster Presenter: Javad Wahadat, MD, MSc – Erasmus University Medical Center

  • 8:30 AM – 10:30 AM ET
    0325: A Multianalyte Assay Panel with Cell-bound Complement Activation Products Demonstrates Clinical Utility for the Diagnosis and Treatment of Systemic Lupus Erythematosus

    Abstract Poster Presenter: Roberta Alexander, PhD, PharmD – Exagen

  • 8:30 AM – 10:30 AM ET
    0352: Native American and African American Rheumatic Disease Patients Exhibit Accelerated Biological Aging Compared to European Americans

    Abstract Poster Presenter: Joseph Kheir, MSc – Oklahoma Medical Research Foundation

  • 8:30 AM – 10:30 AM ET
    0353: Soluble Urine ALCAM Reflects Renal Disease Activity in Lupus Nephritis

    Abstract Poster Presenter: Dalena Chu, MSc – Equillium, Inc.

  • 8:30 AM – 10:30 AM ET
    0354: A Cross-Sectional Study of Rheumatoid Arthritis Diagnoses in Patients with Systemic Lupus Erythematosus

    Abstract Poster Presenter: Kathryn Starzyk, MSc – OM1, Inc

  • 8:30 AM – 10:30 AM ET
    0355: Utilization of a Clinical Data Research Network to Assess Systemic Lupus International Collaborating Clinics Classification Criteria Attributes in Patients with Systemic Lupus Erythematosus

    Abstract Poster Presenter: Noah Forrest, BS – Feinberg School of Medicine

  • 8:30 AM – 10:30 AM ET
    0356: The Role of Neutrophils in the Clinical Severity of Lupus Nephritis Patients with Concurrent Skin Disease

    Abstract Poster Presenter: Lais Osmani, MD – Yale University

  • 8:30 AM – 10:30 AM ET
    0326: Apolipoprotein L1 (APOL1) in African-American SLE: Frequency and Clinical Associations

    Abstract Poster Presenter: Michelle A. Petri, MD, MPH – Johns Hopkins University School of Medicine

  • 8:30 AM – 10:30 AM ET
    0327: Lipoprotein(a) in Systemic Lupus Erythematosus Is Associated with History of Proteinuria and Renal Insufficiency

    Abstract Poster Presenter: Caoilfhionn Connolly, MD – Johns Hopkins

  • 8:30 AM – 10:30 AM ET
    0328: Natural Language Processing to Identify Lupus Nephritis Phenotype in Electronic Health Records

    Abstract Poster Presenter: Yu Deng, PhD student – Northwestern University

  • 8:30 AM – 10:30 AM ET
    0329: Racial and Ethnic Disparities in Risk of End-Organ Disease Following SLE Diagnosis in a Multi-Ethnic Cohort

    Abstract Poster Presenter: Alfredo Aguirre, MD – University of California, San Francisco

  • 8:30 AM – 10:30 AM ET
    0330: Serologic Phenotypes Distinguish SLE Patients with Myositis And/or Interstitial Lung Disease (ILD)

    Abstract Poster Presenter: Thaisa Cotton, MD – McGill University

  • 8:30 AM – 10:30 AM ET
    0331: Urinary MicroRNAs as Systemic Lupus Erythematosus Biomarkers and Its Potential for Accurate Assessment of Disease Severity

    Abstract Poster Presenter: Hiroki Yamaguchi, PhD – Craif Inc.

  • 8:30 AM – 10:30 AM ET
    Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)
  • 8:30 AM – 10:30 AM ET
    0046: Psoriatic Arthritis Skin Is Transcriptionally Different to Psoriasis Skin and Enriched in Immunoglobulin Transcripts

    Abstract Poster Presenter: Hanna Johnsson, PhD, MBChB, MRCP – University of Glasgow

  • 8:30 AM – 10:30 AM ET
    0047: A Role for Neutrophils in Disease Onset and Severity of Spondyloarthritis

    Abstract Poster Presenter: Ruth J. Napier, PhD – Oregon Health & Science University

  • 8:30 AM – 10:30 AM ET
    0048: A Novel Technology to Study the Role of Intestinal Biology in Spondyloarthritis Pathogenesis: Human Colonic Organoids and Epithelial Monolayers

    Abstract Poster Presenter: Tejpal Gill, PhD – OHSU

  • 8:30 AM – 10:30 AM ET
    0049: CC-99677, a Novel, Selective, Oral MK2 Inhibitor, Sustainably Reduces Pro-inflammatory Cytokine Production and Ameliorates Inflammation in the Mannan-Induced Murine Model of Psoriasis and Psoriatic Arthritis

    Abstract Poster Presenter: Rajula Gaur, PhD – BMS

  • 8:30 AM – 10:30 AM ET
    0050: Integrative Analysis of mRNAs to Identify Sex Differences in Th-17 Mediated Inflammation in Ankylosing Spondylitis

    Abstract Poster Presenter: Maricela Haghiac, PhD – Metrohealth Medical Center

  • 8:30 AM – 10:30 AM ET
    0051: Identification of Biomarkers and Deregulated Pathways in Psoriatic Arthritis Through Proteomic Analysis of Synovial Fluid

    Abstract Poster Presenter: Jacqueline Lai, BSc – McMaster University

  • 8:30 AM – 10:30 AM ET
    0052: HLA-B27 Is Associated with Altered Mucosal IgA Response to Oral and Fecal Microbiota in Patients with Axial Spondyloarthritis

    Abstract Poster Presenter: Tejpal Gill, PhD – OHSU

  • 8:30 AM – 10:30 AM ET
    0053: Susceptibility Factors for Psoriatic Arthritis Single-cell RNA-Sequencing of Patients with Psoriatic Disease

    Abstract Poster Presenter: Ameth N. Garrido, -None- – University of Toronto

  • 8:30 AM – 10:30 AM ET
    0054: TCR Immune Profiling of Patients with Psoriatic Disease

    Abstract Poster Presenter: Ameth N. Garrido, -None- – University of Toronto

  • 8:30 AM – 10:30 AM ET
    0055: Time Course of Intestinal Permeability and Intestinal Inflammation in Rat Adjuvant-induced Arthritis

    Abstract Poster Presenter: Sophie Hecquet, Rheumatology resident, PhD student – Service de rhumatologie, CHU de Besançon

  • 8:30 AM – 10:30 AM ET
    0056: Peripheral Blood Immune Cell Profiling in Psoriatic Arthritis: Comparison of Patients with Healthy Controls

    Abstract Poster Presenter: Lihi Eder, MD, PhD – University of Toronto

  • 8:30 AM – 10:30 AM ET
    0057: Molecular Profiling of Radiographic Axial Spondyloarthritis Patients Reveals an Association Between Innate and Adaptive Cell Populations and Therapeutic Response to Adalimumab

    Abstract Poster Presenter: Rita Torres, MD – Hospital Egas Moniz

  • 8:30 AM – 10:30 AM ET
    0058: Effect of Anti-inflammatory Drugs on Intestinal Epithelial Damage and Bacterial Translocation in the Adjuvant-induced Arthritis Model

    Abstract Poster Presenter: Sophie Hecquet, Rheumatology resident, PhD student – Service de rhumatologie, CHU de Besançon

  • 8:30 AM – 10:30 AM ET
    0059: Deep Immune Cell Profiling of Tissue Microenvironment Using Imaging Mass Cytometry in Psoriatic Disease

    Abstract Poster Presenter: Lihi Eder, MD, PhD – University of Toronto

  • 8:30 AM – 10:30 AM ET
    0060: Lipidomic Profiling Identifies Different Expression of Oxylipins Between Synovial Tissue and Plasma of Patients with Rheumatoid and Psoriatic Arthritis

    Abstract Poster Presenter: Roxana Coras, MD, PhD – University of California San Diego/Department of Medicine, Autonomous University of Barcelona

  • 8:30 AM – 10:30 AM ET
    0061: Harnessing Spatially-Resolved Gene Expression to Characterize the Transcriptional Landscape of Psoriatic Skin

    Abstract Poster Presenter: Rochelle Castillo, MD – NYU Langone Health

  • 8:30 AM – 10:30 AM ET
    0062: Axial Spondyloarthritis and Its Related Immune-Mediated Diseases Share a Gut Microbiome Signature Besides Their Own Distinctive Profile

    Abstract Poster Presenter: Valeria Rios Rodriguez, MD – Charité University Medicine Berlin

  • 8:30 AM – 10:30 AM ET
    0063: Development of a Novel Cartilage Model Co-cultured with Conditioned Medium from Th17 Cells to Explore the Effect of IL-17A on Joint Tissue Remodeling

    Abstract Poster Presenter: Solveig S. Groen, MSc – University of Copenhagen

  • 8:30 AM – 10:30 AM ET
    0064: Prevalence, Incidence and Predictor Features of Uveitis in Spondyloarthritis in a Canadian Cohort

    Abstract Poster Presenter: Vanessa Ocampo, MD – university of toronto

  • 8:30 AM – 10:30 AM ET
    0065: Altered Expression of Several miRNAs in Axial Spondyloarthritis Patients with High Disease Activity

    Abstract Poster Presenter: Jiri Baloun, PhD – Institute of Rheumatology

  • 8:30 AM – 10:30 AM ET
    0066: Characterization of αβTCR of HLA-B*27-Restricted CD8 T-Cell Clones Associated with Spondyloarthropathies

    Abstract Poster Presenter: Jose Garrido Mesa, PhD – King's College London

  • 8:30 AM – 10:30 AM ET
    0067: Mendelian Randomisation Analysis of Protein Quantitative Trait Loci with Ankylosing Spondylitis Reveals Causative Involvement of Key Effector Proteins and Pathways

    Abstract Poster Presenter: Nicholas Harvey, PhD – Molecular Genetics

  • 8:30 AM – 10:30 AM ET
    0068: Gut Bacteria Causing Ankylosing Spondylitis Identified Through Mendelian Randomization Studies

    Abstract Poster Presenter: Nicholas Harvey, PhD – Molecular Genetics

  • 8:30 AM – 10:30 AM ET
    Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)
  • 8:30 AM – 10:30 AM ET
    0357: Identifying Predictors of Unemployment in Axial Spondyloarthropathy: Data from the Ankylosing Spondylitis Registry of Ireland

    Abstract Poster Presenter: Sinead Maguire, MB, MRCP, BAO – St James' Hospital

  • 8:30 AM – 10:30 AM ET
    0366: Why Is It so Difficult for AxSpA Patients to Find a Job? Results from the European Map of Axial Spondyloarthritis (EMAS)

    Abstract Poster Presenter: Marco Garrido-Cumbrera, Prof; PhD – Health & Territory Research (HTR), University of Seville

  • 8:30 AM – 10:30 AM ET
    0367: Can Belonging to an AxSpA Patient Organization Be Associated with Benefits to Its Members? Results from the European Map of Axial Spondyloarthritis (EMAS)

    Abstract Poster Presenter: Marco Garrido-Cumbrera, Prof; PhD – Health & Territory Research (HTR), University of Seville

  • 8:30 AM – 10:30 AM ET
    0368: Geographical Prevalence of Family History in Patients with Axial SpA and Its Association with HLA-B27: Data from the Worldwide ASAS-perSpA Study

    Abstract Poster Presenter: Miranda van Lunteren, PhD, MSc – Leiden University Medical Center

  • 8:30 AM – 10:30 AM ET
    0369: High Frequency of Complications in Axial Spondyloarthropathy Pregnancies: Emerging Data from the Ankylosing Spondylitis Registry of Ireland

    Abstract Poster Presenter: Sinead Maguire, MB, MRCP, BAO – St James' Hospital

  • 8:30 AM – 10:30 AM ET
    0370: Awareness and Attitudes Regarding Axial Spondyloarthritis Among Primary Care Providers

    Abstract Poster Presenter: Yuliya Afinogenova, MD – Yale

  • 8:30 AM – 10:30 AM ET
    0371: Self-referral Strategy for Early Diagnosis of Axial Spondyloarthritis- Preliminary Analysis from Finding Axial Spondyloarthritis Study

    Abstract Poster Presenter: Yuliya Afinogenova, MD – Yale

  • 8:30 AM – 10:30 AM ET
    0372: Impact of Gender and Age on Ankylosing Spondylitis Patient Profiles at Golimumab Initiation and 12-Month Outcomes

    Abstract Poster Presenter: Ariel Masetto, MD – Universite de Sherbrooke

  • 8:30 AM – 10:30 AM ET
    0373: Self-monitoring of Disease Activity with a Smartphone App Is Feasible in Routine Clinical Management of Patients with Axial Spondyloarthritis – a Proof of Concept Study

    Abstract Poster Presenter: Uta Kiltz, PhD – Rheumazentrum Ruhrgebiet

  • 8:30 AM – 10:30 AM ET
    0374: Validation of the Ankylosing Spondylitis Disease Activity Score with a Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study

    Abstract Poster Presenter: Fabian Proft, MD – Charité Universitätsmedizin Berlin

  • 8:30 AM – 10:30 AM ET
    0375: Optimizing a Referral Strategy for Patients with a High Probability of Axial Spondyloarthritis:the Role of Age and Symptom Duration

    Abstract Poster Presenter: Fabian Proft, MD – Charité Universitätsmedizin Berlin

  • 8:30 AM – 10:30 AM ET
    0358: Work Participation in Patients with Axial Spondyloarthritis in Germany: Results from a Multicenter, Observational Survey

    Abstract Poster Presenter: Uta Kiltz, PhD – Rheumazentrum Ruhrgebiet

  • 8:30 AM – 10:30 AM ET
    0376: Impact of Patient and Disease Characteristics on Global Functioning and Health in Patients with Axial Spondyloarthritis: A Bayesian Network Analysis of Data from an Early axSpA Cohort

    Abstract Poster Presenter: Uta Kiltz, PhD – Rheumazentrum Ruhrgebiet

  • 8:30 AM – 10:30 AM ET
    0377: The Prevalence of Inflammatory Back Pain and HLA-B27 in a Large Population-Based Cohort in the Netherlands

    Abstract Poster Presenter: Stan Kieskamp, MD – University Medical Center Groningen

  • 8:30 AM – 10:30 AM ET
    0378: Comparison of Demographic, Clinic and Radiological Features of Axial Spondyloarthritis Patients with and Without Accompanying Familial Mediterranean Fever

    Abstract Poster Presenter: Levent Kilic, MD – Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology

  • 8:30 AM – 10:30 AM ET
    0379: Pain Sensitivity in Axial Spondyloarthritis – Comparisons Between Patients and Controls, Women and Men, and Between Different Pain Groups

    Abstract Poster Presenter: Elisabet Lindqvist, MD, PhD – Department of Rheumatology, Skane University Hospital, Lund

  • 8:30 AM – 10:30 AM ET
    0380: Sick Leave and Its Predictors in Early Axial Spondyloarthritis: The Role of Clinical and Socioeconomic Factors. Five-year Data from the DESIR Cohort

    Abstract Poster Presenter: Elena Nikiphorou – Leiden University Medical Center & King's College London

  • 8:30 AM – 10:30 AM ET
    0381: How Do Clinical and Socioeconomic Factors Impact on Work Disability in Early Axial Spondyloarthritis? Five-year Data from the DESIR Cohort

    Abstract Poster Presenter: Elena Nikiphorou – Leiden University Medical Center & King's College London

  • 8:30 AM – 10:30 AM ET
    0382: Six-year Results from the Esperanza Cohort: Evaluation of Clinical Features, Disease Activity Measures and Treatment Aspects in Axial and Peripheral Early Spondyloarthritis

    Abstract Poster Presenter: Carolina Tornero-Marin, RhMSUS – La Paz Hospital

  • 8:30 AM – 10:30 AM ET
    0383: Differences Between Male vs. Female Presenting with Back Pain in an Integrated Delivery System

    Abstract Poster Presenter: Aniket A. Kawatkar, PhD;MS;BS – Kaiser Permanente Southern California

  • 8:30 AM – 10:30 AM ET
    0384: A Tough Cell: The Argument for a Biomarker of Clinical and Imaging Outcomes in Spondyloarthritis: The Neutrophil Lymphocyte Ratio and the Platelet Lymphocyte Ratio

    Abstract Poster Presenter: Rouhin Sen, MD, MS – University of Colorado

  • 8:30 AM – 10:30 AM ET
    0385: The Diagnostic Utility of Serum interleukin-22 in Patients with Suspected Axial Spondyloarthritis

    Abstract Poster Presenter: Michal Sagiv, MD – Bar Ilan university/ Sheba - Tel Hasomer hospital

  • 8:30 AM – 10:30 AM ET
    0359: Patient Journey with Axial Spondyloarthritis: Critical Issues from the Patient Perspective. Results from the European Map of Axial Spondyloarthritis (EMAS)

    Abstract Poster Presenter: Marco Garrido-Cumbrera, Prof; PhD – Health & Territory Research (HTR), University of Seville

  • 8:30 AM – 10:30 AM ET
    0386: Delay to Diagnosis in Axial Spondyloarthritis: The Gap Is Closing, but Persistent Association with Severe Disease

    Abstract Poster Presenter: Maria McWalter, MD – Galway University Hospitals

  • 8:30 AM – 10:30 AM ET
    0360: Factors Associated with Pain Intensity in Axial Spondyloarthritis. Results from the EuropeanMap of Axial Spondyloarthritis (EMAS)

    Abstract Poster Presenter: Marco Garrido-Cumbrera, Prof; PhD – Health & Territory Research (HTR), University of Seville

  • 8:30 AM – 10:30 AM ET
    0361: Factors Associated with Engaging in Physical Activity in Axial Spondyloarthritis. Results from the European Map of Axial Spondyloarthritis (EMAS)

    Abstract Poster Presenter: Marco Garrido-Cumbrera, Prof; PhD – Health & Territory Research (HTR), University of Seville

  • 8:30 AM – 10:30 AM ET
    0362: Achievement of Stringent Thresholds of Disease Control Is Associated with Reduced Burden on Work and Household Productivity in Patients with Axial Spondyloarthritis

    Abstract Poster Presenter: Martin Rudwaleit, MD – University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany

  • 8:30 AM – 10:30 AM ET
    0363: Disease Course and Disease Burden in Patients with Axial Spondyloarthritis: Results from 5-year Multicountry Prospective Observational Study

    Abstract Poster Presenter: Denis Poddubnyy, MD, MSc – Charité - Universitätsmedizin Berlin

  • 8:30 AM – 10:30 AM ET
    0364: Dose Tapering of TNF Inhibitors in Patients with Axial Spondyloarthritis in Routine Care – 2-year Clinical and MRI Outcomes and Predictors of Successful Tapering

    Abstract Poster Presenter: Marie Wetterslev, MD – Rigshospitalet, Copenhagen

  • 8:30 AM – 10:30 AM ET
    0365: A Cluster Analysis in Patients with Axial Spondyloarthritis Using TNFi Based on Clinical Characteristics

    Abstract Poster Presenter: Seulkee Lee, MD, PhD – Samsung Medical Center

  • 8:30 AM – 10:30 AM ET
    Systemic Sclerosis & Related Disorders – Clinical Poster I (0387–0413)
  • 8:30 AM – 10:30 AM ET
    0387: Predictors for Progressive Fibrosis in Patients with Connective Tissue Disease Associated Interstitial Lung Diseases

    Abstract Poster Presenter: Yu-Hsiang Chiu, MD – University Medical Centre Utrecht

  • 8:30 AM – 10:30 AM ET
    0388: Prediction Tool for Damage Accrual Trajectory in Incident Systemic Sclerosis

    Abstract Poster Presenter: Ariane Barbacki, MD, FRCP – McGill University, Montréal

  • 8:30 AM – 10:30 AM ET
    0389: Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States

    Abstract Poster Presenter: Elana J. Bernstein, MD – Columbia University

  • 8:30 AM – 10:30 AM ET
    0390: Vaccination Against COVID-19: Self-Reported Experiences of Patients with Systemic Sclerosis in the Scleroderma Patient-centered Intervention Network (SPIN) Cohort

    Abstract Poster Presenter: Kimberly F. Showalter, MD, MS – Hospital for Special Surgery

  • 8:30 AM – 10:30 AM ET
    0391: High Frequency Ultrasound Imaging of Skin Thickness in Patients with Early Diffuse Cutaneous Systemic Sclerosis: An Objective Outcome Measure to Track Change over Time

    Abstract Poster Presenter: Andrea Murray, PhD – University of Manchester

  • 8:30 AM – 10:30 AM ET
    0392: Faecal Incontinence in Scleroderma: Prevalence, Impact and Response to Sacral Neuromodulation in an Single Centre Observational Cohort

    Abstract Poster Presenter: Nikhil Suresh, n/a – LIRMM

  • 8:30 AM – 10:30 AM ET
    0393: Severity and Impact of Gastrointestinal Symptoms in Patients with SSc-ILD Treated with Nintedanib: Data from SENSCIS-ON

    Abstract Poster Presenter: Dinesh Khanna, MD, MSc – University of Michigan

  • 8:30 AM – 10:30 AM ET
    0394: Hyperspectral Imaging in Systemic Sclerosis-Raynaud Phenomenon

    Abstract Poster Presenter: Akash Gupta, MD – Yale University School of Medicine

  • 8:30 AM – 10:30 AM ET
    0395: RNA Polymerase III Autoantibody Levels and Risk of Systemic Sclerosis in Patients with Raynaud Phenomenon

    Abstract Poster Presenter: Megan M. Lockwood, MD – Massachusetts General Hospital

  • 8:30 AM – 10:30 AM ET
    0396: Esophageal Involvement and Gastroesophageal Reflux Disease in Patients with SSc-ILD: Data from a Sub-Study of the SENSCIS Trial

    Abstract Poster Presenter: Michael Kreuter, MD – Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research

  • 8:30 AM – 10:30 AM ET
    0397: Safety and Persistence of Monthly Intravenous Iloprost in Systemic Sclerosis

    Abstract Poster Presenter: Patricia Martins, Sr, MD – Centro Hospitalar Universitário Lisboa Norte - Hospital de Santa Maria

  • 8:30 AM – 10:30 AM ET
    0398: Performance of ACR CRISS Score and Revised ACR CRISS Response in a Phase 3 Trial of Lenabasum in Diffuse Cutaneous Systemic Sclerosis (dcSSc) in Which Background Immunosuppressive Therapies (bIST) Were Allowed

    Abstract Poster Presenter: Dinesh Khanna, MD, MSc – University of Michigan

  • 8:30 AM – 10:30 AM ET
    0399: Nailfold Videocapillaroscopy Findings and Associations with Organ Involvement in Mixed Connective Tissue Disease

    Abstract Poster Presenter: Camille Kasser – Université de Paris, Service de Rhumatologie, Hôpital Cochin, AP-HP.CUP

  • 8:30 AM – 10:30 AM ET
    0400: Item Development for the Assessment of Systemic Sclerosis-associated Raynaud’s Phenomenon (ASRAP) Questionnaire

    Abstract Poster Presenter: John D. Pauling, PhD, BSc, FRCP, MBBCH – Royal National Hospital for Rheumatic Diseases

  • 8:30 AM – 10:30 AM ET
    0401: Item Reduction for the Assessment of Systemic Sclerosis-associated RAynaud’s Phenomenon (ASRAP) Questionnaire Using Data from the International Multicentre ASRAP Validation Study

    Abstract Poster Presenter: John D. Pauling, PhD, BSc, FRCP, MBBCH – Royal National Hospital for Rheumatic Diseases

  • 8:30 AM – 10:30 AM ET
    0402: What Is the Patient’s Perspective on Symptoms Experience in Limited Cutaneous Systemic Sclerosis?

    Abstract Poster Presenter: Alain Lescoat, MD, PhD – CHU Rennes - University Rennes 1

  • 8:30 AM – 10:30 AM ET
    0403: Effect of Nintedanib on KL-6 in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

    Abstract Poster Presenter: Shervin Assassi, MD, MS – University of Texas McGovern Medical School at Houston

  • 8:30 AM – 10:30 AM ET
    0404: Perifollicular Hypopigmentation in Systemic Sclerosis: Associations with Clinical Features and Internal Organ Involvement

    Abstract Poster Presenter: Melody Chung, MD, MS – Johns Hopkins University

  • 8:30 AM – 10:30 AM ET
    0405: Retrospective Study on the Prognostic Value of Cardiac Magnetic Resonance Imaging Abnormalities in Systemic Sclerosis

    Abstract Poster Presenter: Hao Cheng Shen, MD – University of Montreal

  • 8:30 AM – 10:30 AM ET
    0406: Gender Differences in Clinical Features and Outcomes of Systemic Sclerosis: Analysis of Reuma.pt/SSc Registry

    Abstract Poster Presenter: Raquel de Freitas, MD – Hospital Garcia de orta

  • 8:30 AM – 10:30 AM ET
    0407: The Clinical Role of T1 Mapping Cardiac Magnetic Resonance Imaging for Detecting Cardiac Involvement in the Early Stage of Systemic Sclerosis

    Abstract Poster Presenter: Munkhtuul Purevsuren, MD – Department of Cardiovascular Medicine, The University of Tokyo

  • 8:30 AM – 10:30 AM ET
    0408: A Histogram-based Densitometry Index to Support the Identification and the Assessment of Severity of Interstitial Lung Disease in Systemic Sclerosis: Applicability in Conventional and Low-dose Computed Tomography

    Abstract Poster Presenter: cosimo bruni, MD – University of Florence

  • 8:30 AM – 10:30 AM ET
    0409: Factors Predicting Mortality in an Indian Cohort of Systemic Sclerosis

    Abstract Poster Presenter: Sundaram T G, MD, DM – Sanjay Gandhi Post Graduate Institute of Medical Sciences

  • 8:30 AM – 10:30 AM ET
    0410: Long-term Outcomes of Vascular Grafting of Medium Sized Vessels of the Wrist and Hand in Patients with Medication Refractory Systemic Sclerosis Related Raynaud’s Phenomenon at the University of Pennsylvania from 2009-2019

    Abstract Poster Presenter: Nora Hajnoczky, MD – Albert Einstein Healthcare Network

  • 8:30 AM – 10:30 AM ET
    0411: Pharmacokinetics, Safety, and Efficacy of Subcutaneous Brodalumab for Systemic Sclerosis with Moderate-to-severe Skin Thickening: A Single-arm, Open-label, Multi-dose, Phase 1 Trial

    Abstract Poster Presenter: Takemichi Fukasawa, MD, PhD – The University of Tokyo Graduate School of Medicine

  • 8:30 AM – 10:30 AM ET
    0412: Prevalence, Distribution, Clinical Correlates and Outcomes of Upper Extremity Macrovascular Disease in Systemic Sclerosis: Results from a Single Center Referral Cohort (2001-2018)

    Abstract Poster Presenter: Ashima Makol, MD – Mayo Clinic, Rochester, MN

  • 8:30 AM – 10:30 AM ET
    0413: Predictors of ILD Development and Timing of Onset in Systemic Sclerosis: A Canadian Cohort

    Abstract Poster Presenter: Jessica Kapralik, MD, FRCPC – McMaster University

  • 8:30 AM – 10:30 AM ET
    Vasculitis – ANCA-Associated Poster (0414–0436)
  • 8:30 AM – 10:30 AM ET
    0414: Effect of Induction Therapies on Ear, Nose and Throat Involvement in Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis: Results from a Multi-center Cohort Study

    Abstract Poster Presenter: Roline M. Krol, MD – UMC Utrecht

  • 8:30 AM – 10:30 AM ET
    0415: Utility of the 22-Item Sinonasal Outcome Test Patient-Reported Outcome Instrument in ANCA-Associated Vasculitis

    Abstract Poster Presenter: Ellen Romich, MD – Hospital of the University of Pennsylvania

  • 8:30 AM – 10:30 AM ET
    0416: Pharmacological Response of Rituximab Based on Dose Intensity in Maintenance Therapy of ANCA-Associated Vasculitis

    Abstract Poster Presenter: Jason M. Springer, MD, MS – Vanderbilt University Medical Center

  • 8:30 AM – 10:30 AM ET
    0417: Neurologic Involvement in ANCA-associated Vasculitis: Data from Multicenter Longitudinal Observational Study

    Abstract Poster Presenter: Rula A. Hajj-Ali, MD – Cleveland Clinic

  • 8:30 AM – 10:30 AM ET
    0418: Longitudinal Patterns of Renal Function in ANCA-Associated Vasculitis

    Abstract Poster Presenter: Jennifer Hanberg, MD – Massachusetts General Hospital

  • 8:30 AM – 10:30 AM ET
    0419: Post-induction ANCA Titer Does Not Predict Mortality or Renal Outcomes: A Target Trial Emulation Study

    Abstract Poster Presenter: Gregory McDermott, MD – Brigham and Women's Hospital

  • 8:30 AM – 10:30 AM ET
    0420: Development and Validation of a Simulation Model for Maintenance Treatment in ANCA-Associated Vasculitis

    Abstract Poster Presenter: Zachary S. Wallace, MD, MSc – Massachusetts General Hospital

  • 8:30 AM – 10:30 AM ET
    0421: Negative vs. Positive Antineutrophil Cytoplasmic Antibody Granulomatosis with Polyangiitis, a Case-control Study

    Abstract Poster Presenter: Marta Casal Moura, MD, MS, MPH, -None- – Mayo Clinic

  • 8:30 AM – 10:30 AM ET
    0422: Cancer in Patients with ANCA-associated Vasculitis: Which Came First, the Chicken or the Egg?

    Abstract Poster Presenter: Omer Karadag, MD – Hacettepe University, Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine

  • 8:30 AM – 10:30 AM ET
    0423: Urine and Plasma Complement Ba Levels During Flares of Nephritis in Patients with ANCA-Associated Vasculitis

    Abstract Poster Presenter: Salem Almaani, MD, MS – The Ohio State University Medical Center

  • 8:30 AM – 10:30 AM ET
    0424: Incremental Healthcare Costs of Eosinophilic Granulomatosis with Polyangiitis (EGPA) Compared to Asthma: Retrospective Analysis of Commercial Claims Data in the United States (US)

    Abstract Poster Presenter: Christopher F F. Bell – GlaxoSmithKline

  • 8:30 AM – 10:30 AM ET
    0425: Diagnostic Accuracy of Muscle MRI for Muscular Vasculitis in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis: A Pilot Study

    Abstract Poster Presenter: Ryuta Inaba, MD – Kurashiki Central Hospital

  • 8:30 AM – 10:30 AM ET
    0426: Ocular Manifestations of ANCA-Associated Vasculitis

    Abstract Poster Presenter: Mats Junek, MD, MSc – McMaster University

  • 8:30 AM – 10:30 AM ET
    0427: Increased Risk of Severe Infections and Mortality in Patients with Newly Diagnosed Anti-neutrophil Cytoplasmic Antibody–associated Vasculitis: A Population-based Study

    Abstract Poster Presenter: Kai Zhao, MSc – Arthritis Research Canada

  • 8:30 AM – 10:30 AM ET
    0428: ANCA Positivity and ANCA Associated Vasculitis in Patients with Rheumatoid Arthritis

    Abstract Poster Presenter: Courtney O'Brien, DO – UCLA

  • 8:30 AM – 10:30 AM ET
    0429: Causes and Characteristics of Death in ANCA-Associated Vasculitis - A Large, Real-Life, Contemporary Cohort Analysis

    Abstract Poster Presenter: Guy Katz, MD – Massachusetts General Hospital

  • 8:30 AM – 10:30 AM ET
    0430: Interstitial Lung Disease in ANCA-Associated Vasculitis: Associated Factors and Outcomes

    Abstract Poster Presenter: Brett Doliner, MD – Massachusetts General Hospital

  • 8:30 AM – 10:30 AM ET
    0431: Clinical Characteristics and Outcomes of ANCA-Associated and Non Immune-Mediated Hypertrophic Pachymeningitis: A Comparative Study

    Abstract Poster Presenter: Eduardo Martin-Nares, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

  • 8:30 AM – 10:30 AM ET
    0432: Anti-IL5 Therapy in Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Longitudinal Follow-up Study ≥ 24months

    Abstract Poster Presenter: Allyson C. Egan, BSc, MRCP – Vasculitis & Lupus Centre, Department of Medicine, University of Cambridge

  • 8:30 AM – 10:30 AM ET
    0433: Use of 2-Mercaptoethane Sodium Sulfonate Prophylaxis in Cyclophosphamide-Treated Patients with ANCA-Associated Vasculitis: Results of an Electronic Survey

    Abstract Poster Presenter: Lukas Joos, MMed – Kantonsspital St.Gallen

  • 8:30 AM – 10:30 AM ET
    0434: Protein Profiling in Pre-dating Samples Separate MPO-ANCA Vasculitis from PR3-ANCA Vasculitis

    Abstract Poster Presenter: Mikael Brink, n/a – Umeå Universitet

  • 8:30 AM – 10:30 AM ET
    0435: Myeloperoxidase Activity in Individuals with Antineutrophil Cytoplasmic Antibodies (ANCA) Can Be Inhibited by RLS-0071

    Abstract Poster Presenter: Parvathi Kumar, MBBS – ReAlta Life Sciences Inc

  • 8:30 AM – 10:30 AM ET
    0436: Ocular and Orbital Manifestations of Granulomatosis with Polyangiitis: A Systematic Review of Published Cases

    Abstract Poster Presenter: Allen Tsiyer, -None- – American University of the Caribbean

  • 9:00 AM – 10:00 AM ET
    Abstracts: Immunological Complications of Therapy (0437–0440)
    Virtual Room 11

    Abstract Moderator: Clifton O. Bingham, III – Johns Hopkins University

  • 9:00 AM – 9:15 AM ET
    0437: Factors Associated with Reduced Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) Treated with Rituximab
    Virtual Room 11

    Presenting Author: Victoria Furer – Tel Aviv Sourasky Medical Center

  • 9:15 AM – 9:30 AM ET
    0438: Rheumatological Immune-Related Adverse Events of Immune Checkpoint Inhibitors Based on the FDA Adverse Event Reporting System
    Virtual Room 11

    Presenting Author: Alicia Rodriguez-Pla, MD, PhD, RhMSUS, MPH – Mayo Clinic in Arizona

  • 9:30 AM – 9:45 AM ET
    0439: Predictors of Rheumatic Immune-related Adverse Events and de Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor-treatment for Cancer
    Virtual Room 11

    Presenting Author: Jeffrey A. Sparks, MD, MSc – Brigham and Women's Hospital

  • 9:45 AM – 10:00 AM ET
    0440: Association Between Rheumatic Autoantibody Positivity and Immune-related Adverse Events
    Virtual Room 11

    Presenting Author: Kristen Mathias, MD – University of Chicago

  • 9:00 AM – 10:00 AM ET
    Abstracts: Muscle Biology, Myositis & Myopathies (0441–0444)
    Virtual Room 7

    Abstract Moderator: Lisa Christopher-Stine, MD, MPH – Johns Hopkins University

  • 9:00 AM – 9:15 AM ET
    0441: A Randomized, Double-blind, Placebo-controlled Study of Arimoclomol in Patients with Inclusion Body Myositis
    Virtual Room 7

    Presenting Author: Pedro M. Machado, MD, PhD, FRCP – University College London

  • 9:15 AM – 9:30 AM ET
    0442: Identification of Plexin D1 on Circulating Extracellular Vesicles as a Potential Biomarker of Polymyositis and Dermatomyositis
    Virtual Room 7

    Presenting Author: Kenichi Uto, MSc – Kobe University Hospital

  • 9:30 AM – 9:45 AM ET
    0443: Safety and Efficacy of Belimumab in the Treatment of Adult Idiopathic Inflammatory Myositis (Polymyositis and Dermatomyositis)
    Virtual Room 7

    Presenting Author: Galina Marder, MD – Northwell Health

  • 9:45 AM – 10:00 AM ET
    0444: COVID-19 Vaccination in Autoimmune Disease (CoVAD) Study: Interim Analysis of Safety in Idiopathic Inflammatory Myopathies from a Large Multicentre Global Survey
    Virtual Room 7

    Presenting Author: Latika Gupta, MD, DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences

  • 9:00 AM – 10:00 AM ET
    Pediatric Rheumatology Year in Review & Awards
    Virtual Room 8

    Moderator: Grant Schulert, MD, PhD – Cincinnati Children's Hospital Medical Center

  • 9:00 AM – 9:20 AM ET
    Pediatric Rheumatology Year in Review: Clinical Research
    Virtual Room 8

    Speaker: Mara Becker, MD – Duke University Medical Center/Duke Clinical Research Institute

  • 9:20 AM – 9:40 AM ET
    Pediatric Rheumatology Year in Review: Basic Research
    Virtual Room 8

    Speaker: Tiphanie Vogel, MD, PhD – Baylor College of Medicine

  • 9:40 AM – 10:00 AM ET
    Q&A
    Virtual Room 8
  • 9:00 AM – 10:00 AM ET
    Data Science, Machine Learning & Natural Language Processing
    Virtual Room 10

    Moderator: Julia Lee, PhD, MPH – Northwestern University Feinberg School of Medicine

  • 9:00 AM – 9:20 AM ET
    Principles of Data Science, Machine Learning & Risk Prediction for Rheumatology Studies
    Virtual Room 10

    Speaker: Jamie Collins, PhD – Brigham and Women's Hospital

  • 9:20 AM – 9:40 AM ET
    Data Science & Natural Language Processing for Rheumatology Clinical Practice & Research
    Virtual Room 10

    Speaker: Katherine Liao, MD, MPH – Brigham and Women's Hospital

  • 9:40 AM – 10:00 AM ET
    Q&A
    Virtual Room 10
  • 9:00 AM – 10:00 AM ET
    CPC: The Case for Vasculitis Gets Weaker
    Virtual Room 3

    Moderator: Michael Feely, MD – University of Nebraska Medical Center

  • 9:00 AM – 9:15 AM ET
    Initial Case Presentation
    Virtual Room 3

    Speaker: Jemima Albayda, MD – Johns Hopkins University

  • 9:15 AM – 9:30 AM ET
    Interpretation & Review of Radiologic Testing
    Virtual Room 3

    Speaker: Shivani Ahlawat, MD – Johns Hopkins University

  • 9:30 AM – 9:45 AM ET
    Interpretation & Review of Histopathology Related to Case
    Virtual Room 3

    Speaker: Thomas E Lloyd, MD, PhD – Johns Hopkins University School of Medicine

  • 9:45 AM – 10:00 AM ET
    Q&A
    Virtual Room 3
  • 9:00 AM – 10:00 AM ET
    The Great Debate: Enhancing Lupus Nephritis Therapy: Is Your Next Step Belimumab or Voclosporin?
    Virtual Room 1

    Moderator: Namrata Singh, MD, MSc – University of Washington

  • 9:00 AM – 9:20 AM ET
    Efficacy & Safety of Belimumab for Lupus Nephritis
    Virtual Room 1

    Speaker: Michelle Petri, MD, MPH – Johns Hopkins University School of Medicine

  • 9:20 AM – 9:30 AM ET
    Q&A
    Virtual Room 1
  • 9:30 AM – 9:50 AM ET
    Efficacy & Safety of Voclosporin for Lupus Nephritis
    Virtual Room 1

    Speaker: Brad Rovin, MD – The Ohio State University

  • 9:50 AM – 10:00 AM ET
    Q&A
    Virtual Room 1
  • 9:00 AM – 10:30 AM ET
    Molecular Insights from the Accelerating Medicines Partnership (AMP) 2021: RA
    Virtual Room 4

    Moderator: Vivianne Malmström, PhD – Karolinska Institutet and Karolinska University Hospital

    Moderator: Anna Helena Jonsson, MD;PhD – Brigham and Women's Hospital

  • 9:00 AM – 9:15 AM ET
    Molecular Deconstruction/Reconstruction of RA in AMP Phase 2 & New Insights on Stromal Cells
    Virtual Room 4

    Speaker: Soumya Raychaudhuri, MD, PhD – Brigham and Women's Hospital

  • 9:15 AM – 9:20 AM ET
    Q&A
    Virtual Room 4
  • 9:20 AM – 9:35 AM ET
    Adaptive Immune Cells In the RA Synovium
    Virtual Room 4

    Speaker: Deepak Rao, MD, PhD – Brigham and Women's Hospital

  • 9:35 AM – 9:40 AM ET
    Q&A
    Virtual Room 4
  • 9:40 AM – 9:55 AM ET
    The Innate Immune-Stromal Cell Interface in RA
    Virtual Room 4

    Speaker: Laura Donlin, PhD – Hospital for Special Surgery

  • 9:55 AM – 10:00 AM ET
    Q&A
    Virtual Room 4
  • 10:00 AM – 10:15 AM ET
    Synovial High-Dimensional Histology & Clinical Outcomes
    Virtual Room 4

    Speaker: Andrew Filer, MD, PhD, FRCP – The University of Birmingham

  • 10:15 AM – 10:20 AM ET
    Q&A
    Virtual Room 4
  • 10:20 AM – 10:30 AM ET
    Q&A
    Virtual Room 4
  • 9:30 AM – 10:30 AM ET
    Abstracts: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science (0445–0448)
    Virtual Room 6

    Abstract Moderator: Robin Dore, MD – Robin K. Dore, MD Inc

  • 9:30 AM – 9:45 AM ET
    0445: Safety and Efficacy of Denosumab vs Risedronate in Patients with Glucocorticoid-Induced Osteoporosis and Rheumatoid Arthritis
    Virtual Room 6

    Presenting Author: Jonathan Adachi, MD – McMaster University/St. Joseph's Healthcare

  • 9:45 AM – 10:00 AM ET
    0446: Clinical Characteristics, Including History of Myocardial Infarction and Stroke, Among US PMO Women Initiating Treatment with Romosozumab and Other Anti-osteoporosis Therapies
    Virtual Room 6

    Presenting Author: Jay Lin – Amgen Inc.

  • 10:00 AM – 10:15 AM ET
    0447: Bone Anabolic Effects of a Novel Orally-Available Small Molecule SIK2/SIK3 Inhibitor
    Virtual Room 6

    Presenting Author: Marc N. Wein, MD, PhD – Massachusetts General Hospital

  • 10:15 AM – 10:30 AM ET
    0448: Bone Microarchitecture Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as Predictor of Incident Fracture in Rheumatic Disease Patients on Long-term Glucocorticoid- a Five-year Longitudinal Study
    Virtual Room 6

    Presenting Author: ho SO, MD – The Chinese University of Hong Kong

  • 9:30 AM – 10:30 AM ET
    Abstracts: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes I (0449–0452)
    Virtual Room 5

    Abstract Moderator: Jean W. Liew, MD, MS – Boston University

  • 9:30 AM – 9:45 AM ET
    0449: Identification of Serum Protein Biomarkers at Baseline to Distinguish Radiographic Progressors from Non-Progressors in Patients with Active Psoriatic Arthritis
    Virtual Room 5

    Presenting Author: Orla Coleman, PhD – Atturos Ltd

  • 9:45 AM – 10:00 AM ET
    0450: Identifying Trajectories of Radiographic Spinal Disease in Ankylosing Spondylitis
    Virtual Room 5

    Presenting Author: Mark C. Hwang, MD – McGovern Medical School at the University of Texas Health Science Center at Houston

  • 10:00 AM – 10:15 AM ET
    0451: Tumor Necrosis Factor Inhibitors Show a Delayed Effect on Radiographic Sacroiliitis Progression in Patients with Early Axial Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception Cohort
    Virtual Room 5